AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|17|200535373|Female|All other|2009-2013|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|21|200535373|Female|All other|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|45|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Anaplastic astrocytoma|2009-2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|180|200535373|Female|Anaplastic astrocytoma|2009-2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40634361|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40110316|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39959221|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|49|39877536|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Anaplastic oligodendroglioma|2009-2013|~|~|~
0-19|~|~|~|Malignant|~|200535373|Female|Anaplastic oligodendroglioma|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Astrocytoma, NOS|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|443|200535373|Female|Astrocytoma, NOS|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|40634361|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40110316|Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|39959221|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|39877536|Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|127|200535373|Female|Choroid plexus|2009-2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|42|200535373|Female|Choroid plexus|2009-2013|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|40634361|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634361|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40110316|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40110316|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39959221|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39959221|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|39877536|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39877536|Female|Choroid plexus|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|39998876|Female|Craniopharyngioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40165421|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|424|200535373|Female|Craniopharyngioma|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|200535373|Female|Craniopharyngioma|2009-2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|40634361|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634361|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|40110316|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40110316|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39959221|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39959221|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|82|39877536|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39877536|Female|Craniopharyngioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Diffuse astrocytoma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|63|200535373|Female|Diffuse astrocytoma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40634361|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|216|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|185|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|202|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|219|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|231|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Embryonal/primitive/medulloblastoma|2009-2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|930|200535373|Female|Embryonal/primitive/medulloblastoma|2009-2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|174|40634361|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|193|40110316|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.5|Malignant|183|39959221|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|182|39877536|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|71|200535373|Female|Ependymoma variants|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200535373|Female|Ependymoma variants|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40110316|Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40110316|Female|Ependymoma variants|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Ependymoma variants|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39877536|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39877536|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Ependymoma/anaplastic ependymoma|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|436|200535373|Female|Ependymoma/anaplastic ependymoma|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40634361|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40110316|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|39959221|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|39877536|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|42|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|91|200535373|Female|Germ Cell Tumors|2009-2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|198|200535373|Female|Germ Cell Tumors|2009-2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40634361|Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|53|40634361|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|22|40110316|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|38|40110316|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Germ Cell Tumors|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|39959221|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|39877536|Female|Germ Cell Tumors|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|44|39877536|Female|Germ Cell Tumors|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Glioblastoma|2009-2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|298|200535373|Female|Glioblastoma|2009-2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40634361|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|40110316|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|39959221|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|39877536|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|231|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|231|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.7|Malignant|260|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|273|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|295|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|72|200535373|Female|Glioma malignant, NOS|2009-2013|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|1317|200535373|Female|Glioma malignant, NOS|2009-2013|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.6|Malignant|253|40634361|Female|Glioma malignant, NOS|2010|0.5|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|21|40110316|Female|Glioma malignant, NOS|2011|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|299|40110316|Female|Glioma malignant, NOS|2011|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|21|39959221|Female|Glioma malignant, NOS|2012|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Malignant|212|39959221|Female|Glioma malignant, NOS|2012|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.6|0.7|0.7|Malignant|259|39877536|Female|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|68|200535373|Female|Hemangioblastoma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200535373|Female|Hemangioblastoma|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39877536|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39877536|Female|Hemangioblastoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40382360|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40576293|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|264|200535373|Female|Hemangioma|2009-2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|200535373|Female|Hemangioma|2009-2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40634361|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40634361|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|61|40110316|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40110316|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|39959221|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39959221|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|39877536|Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39877536|Female|Hemangioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Local Extensions from Regional Tumors|2009-2013|~|~|~
0-19|~|~|~|Malignant|~|200535373|Female|Local Extensions from Regional Tumors|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|200535373|Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|308|200535373|Female|Meningioma|2009-2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|200535373|Female|Meningioma|2009-2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|40634361|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40634361|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40110316|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40110316|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|39959221|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39959221|Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39877536|Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39877536|Female|Meningioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Mixed glioma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|64|200535373|Female|Mixed glioma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40634361|Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Mixed glioma|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|54|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|49|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|48|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|74|40576293|Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|339|200535373|Female|Neoplasm, unspecified|2009-2013|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|91|200535373|Female|Neoplasm, unspecified|2009-2013|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|88|40634361|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634361|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40110316|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|20|40110316|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|63|39959221|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|39959221|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|65|39877536|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|39877536|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|110|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|155|39998876|Female|Nerve sheath, benign and malignant|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|120|40382360|Female|Nerve sheath, benign and malignant|2007|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|145|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|616|200535373|Female|Nerve sheath, benign and malignant|2009-2013|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200535373|Female|Nerve sheath, benign and malignant|2009-2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|40634361|Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40634361|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|40110316|Female|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40110316|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|39959221|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39959221|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|39877536|Female|Nerve sheath, benign and malignant|2013|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39877536|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Neuroepithelial|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|29|200535373|Female|Neuroepithelial|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Neuroepithelial|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|135|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|121|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|131|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|708|200535373|Female|Neuronal/glial, neuronal|2009-2013|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|86|200535373|Female|Neuronal/glial, neuronal|2009-2013|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|142|40634361|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|40634361|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|141|40110316|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40110316|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|147|39959221|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|16|39959221|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|147|39877536|Female|Neuronal/glial, neuronal|2013|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|20|39877536|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Oligodendroglioma|2009-2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|95|200535373|Female|Oligodendroglioma|2009-2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|40634361|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40110316|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39959221|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|157|200535373|Female|Other mesenchymal|2009-2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|200535373|Female|Other mesenchymal|2009-2013|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|22|40634361|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634361|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40110316|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40110316|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|39959221|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39959221|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|39877536|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39877536|Female|Other mesenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|330|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|316|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|309|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|331|40382360|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|329|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|343|40670476|Female|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|200535373|Female|Pilocytic astrocytoma|2009-2013|~|~|~
0-19|0.8|0.9|0.9|Malignant|1751|200535373|Female|Pilocytic astrocytoma|2009-2013|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|374|40634361|Female|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|342|40110316|Female|Pilocytic astrocytoma|2011|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.8|1.0|0.9|Malignant|354|39959221|Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|343|39877536|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|200535373|Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|68|200535373|Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40634361|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40634361|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40110316|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39959221|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|39959221|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39877536|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|39877536|Female|Pineal parenchymal|2013|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|252|39865121|Female|Pituitary|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|293|39998876|Female|Pituitary|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|323|40165421|Female|Pituitary|2006|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|312|40382360|Female|Pituitary|2007|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|356|40576293|Female|Pituitary|2008|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|353|40670476|Female|Pituitary|2009|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|1943|200535373|Female|Pituitary|2009-2013|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|200535373|Female|Pituitary|2009-2013|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|413|40634361|Female|Pituitary|2010|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40634361|Female|Pituitary|2010|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|392|40110316|Female|Pituitary|2011|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40110316|Female|Pituitary|2011|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|405|39959221|Female|Pituitary|2012|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39959221|Female|Pituitary|2012|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|385|39877536|Female|Pituitary|2013|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39877536|Female|Pituitary|2013|~|~|~
0-19|1.7|2.0|1.9|Benign/Borderline|755|39865121|Female|Total|2004|1.8|2.0|1.9
0-19|3.1|3.5|3.3|Malignant|1303|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.1|2.4|2.2|Benign/Borderline|910|39998876|Female|Total|2005|2.1|2.4|2.3
0-19|2.9|3.2|3.1|Malignant|1221|39998876|Female|Total|2005|2.9|3.2|3.1
0-19|2.1|2.4|2.3|Benign/Borderline|917|40165421|Female|Total|2006|2.1|2.4|2.3
0-19|2.9|3.2|3.0|Malignant|1215|40165421|Female|Total|2006|2.9|3.2|3.0
0-19|2.1|2.4|2.3|Benign/Borderline|930|40382360|Female|Total|2007|2.2|2.5|2.3
0-19|3.0|3.4|3.2|Malignant|1286|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.2|2.5|2.4|Benign/Borderline|988|40576293|Female|Total|2008|2.3|2.6|2.4
0-19|3.0|3.3|3.1|Malignant|1270|40576293|Female|Total|2008|3.0|3.3|3.1
0-19|2.3|2.6|2.5|Benign/Borderline|1016|40670476|Female|Total|2009|2.3|2.7|2.5
0-19|3.0|3.3|3.2|Malignant|1277|40670476|Female|Total|2009|3.0|3.3|3.1
0-19|2.6|2.7|2.6|Benign/Borderline|5351|200535373|Female|Total|2009-2013|2.6|2.7|2.7
0-19|3.1|3.2|3.1|Malignant|6288|200535373|Female|Total|2009-2013|3.1|3.2|3.1
0-19|2.5|2.8|2.6|Benign/Borderline|1082|40634361|Female|Total|2010|2.5|2.8|2.7
0-19|3.0|3.3|3.1|Malignant|1266|40634361|Female|Total|2010|2.9|3.3|3.1
0-19|2.5|2.8|2.6|Benign/Borderline|1071|40110316|Female|Total|2011|2.5|2.8|2.7
0-19|3.1|3.5|3.3|Malignant|1311|40110316|Female|Total|2011|3.1|3.5|3.3
0-19|2.6|2.9|2.8|Benign/Borderline|1108|39959221|Female|Total|2012|2.6|2.9|2.8
0-19|2.8|3.2|3.0|Malignant|1189|39959221|Female|Total|2012|2.8|3.1|3.0
0-19|2.5|2.9|2.7|Benign/Borderline|1082|39877536|Female|Total|2013|2.6|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1264|39877536|Female|Total|2013|3.0|3.3|3.2
0-19|0.2|0.3|0.3|Benign/Borderline|110|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|155|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|120|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|145|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|617|200535373|Female|Tumors of Cranial and Spinal Nerves|2009-2013|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200535373|Female|Tumors of Cranial and Spinal Nerves|2009-2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|40634361|Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40634361|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|118|40110316|Female|Tumors of Cranial and Spinal Nerves|2011|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40110316|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|39959221|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39959221|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|39877536|Female|Tumors of Cranial and Spinal Nerves|2013|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39877536|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|188|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.2|3.0|Malignant|1205|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.5|0.5|Benign/Borderline|190|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
0-19|2.7|3.0|2.8|Malignant|1131|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.8
0-19|0.4|0.6|0.5|Benign/Borderline|198|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1147|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.0|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|227|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1221|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|222|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1217|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.8|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|203|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.6|0.5
0-19|2.8|3.1|3.0|Malignant|1196|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|1138|200535373|Female|Tumors of Neuroepthelial Tissue|2009-2013|0.5|0.6|0.6
0-19|2.9|3.0|2.9|Malignant|5901|200535373|Female|Tumors of Neuroepthelial Tissue|2009-2013|2.9|3.0|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|226|40634361|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|2.8|3.1|2.9|Malignant|1187|40634361|Female|Tumors of Neuroepthelial Tissue|2010|2.8|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|230|40110316|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1232|40110316|Female|Tumors of Neuroepthelial Tissue|2011|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|242|39959221|Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.7|0.6
0-19|2.7|3.0|2.8|Malignant|1126|39959221|Female|Tumors of Neuroepthelial Tissue|2012|2.7|3.0|2.8
0-19|0.5|0.7|0.6|Benign/Borderline|238|39877536|Female|Tumors of Neuroepthelial Tissue|2013|0.5|0.7|0.6
0-19|2.8|3.1|3.0|Malignant|1178|39877536|Female|Tumors of Neuroepthelial Tissue|2013|2.8|3.1|3.0
0-19|0.7|0.9|0.8|Benign/Borderline|333|39865121|Female|Tumors of Sellar Region|2004|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|368|39998876|Female|Tumors of Sellar Region|2005|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|398|40165421|Female|Tumors of Sellar Region|2006|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|407|40382360|Female|Tumors of Sellar Region|2007|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|418|40576293|Female|Tumors of Sellar Region|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|444|40670476|Female|Tumors of Sellar Region|2009|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.1|1.2|1.2|Benign/Borderline|2367|200535373|Female|Tumors of Sellar Region|2009-2013|1.1|1.2|1.2
0-19|~|~|~|Malignant|~|200535373|Female|Tumors of Sellar Region|2009-2013|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|503|40634361|Female|Tumors of Sellar Region|2010|1.1|1.4|1.2
0-19|~|~|~|Malignant|~|40634361|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|475|40110316|Female|Tumors of Sellar Region|2011|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40110316|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|483|39959221|Female|Tumors of Sellar Region|2012|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|39959221|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|467|39877536|Female|Tumors of Sellar Region|2013|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|39877536|Female|Tumors of Sellar Region|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|98|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|533|200535373|Female|Tumors of the Meninges|2009-2013|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|44|200535373|Female|Tumors of the Meninges|2009-2013|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|92|40634361|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634361|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|99|40110316|Female|Tumors of the Meninges|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40110316|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|123|39959221|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39959221|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|39877536|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39877536|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|39865121|Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|77|39998876|Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|82|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|72|40382360|Female|Unclassified Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|112|40576293|Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|604|200535373|Female|Unclassified Tumors|2009-2013|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|94|200535373|Female|Unclassified Tumors|2009-2013|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|40634361|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634361|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40110316|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|20|40110316|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|125|39959221|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|39959221|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|120|39877536|Female|Unclassified Tumors|2013|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|39877536|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|22|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|125|200535373|Female|Unique astrocytoma variants|2009-2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|83|200535373|Female|Unique astrocytoma variants|2009-2013|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|40634361|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634361|Female|Unique astrocytoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110316|Female|Unique astrocytoma variants|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40110316|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|29|39959221|Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|39959221|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|26|39877536|Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39877536|Female|Unique astrocytoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|18|209926607|Male|All other|2009-2013|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|39|209926607|Male|All other|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42551070|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42005181|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41820286|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|41820286|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41693957|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Anaplastic astrocytoma|2009-2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|201|209926607|Male|Anaplastic astrocytoma|2009-2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42551070|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42005181|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|41820286|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|41693957|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Anaplastic oligodendroglioma|2009-2013|~|~|~
0-19|~|~|~|Malignant|~|209926607|Male|Anaplastic oligodendroglioma|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42005181|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|41820286|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Astrocytoma, NOS|2009-2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|493|209926607|Male|Astrocytoma, NOS|2009-2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42551070|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|42005181|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|41820286|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|84|41693957|Male|Astrocytoma, NOS|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|178|209926607|Male|Choroid plexus|2009-2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|42|209926607|Male|Choroid plexus|2009-2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|38|42551070|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42551070|Male|Choroid plexus|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42005181|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42005181|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|41820286|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41820286|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41693957|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41693957|Male|Choroid plexus|2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41889233|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|78|42158997|Male|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42367071|Male|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42609915|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|392|209926607|Male|Craniopharyngioma|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|209926607|Male|Craniopharyngioma|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42551070|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42551070|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|42005181|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42005181|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|78|41820286|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41820286|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|41693957|Male|Craniopharyngioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41693957|Male|Craniopharyngioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Diffuse astrocytoma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|79|209926607|Male|Diffuse astrocytoma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42005181|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41820286|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|276|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.8|Malignant|317|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Embryonal/primitive/medulloblastoma|2009-2013|~|~|~
0-19|0.7|0.7|0.7|Malignant|1467|209926607|Male|Embryonal/primitive/medulloblastoma|2009-2013|0.7|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|314|42551070|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|297|42005181|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|282|41820286|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.6|Malignant|267|41693957|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|108|209926607|Male|Ependymoma variants|2009-2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|209926607|Male|Ependymoma variants|2009-2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42551070|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551070|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42005181|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42005181|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41820286|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41820286|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41693957|Male|Ependymoma variants|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41693957|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|105|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Ependymoma/anaplastic ependymoma|2009-2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|565|209926607|Male|Ependymoma/anaplastic ependymoma|2009-2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|120|42551070|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42005181|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|41820286|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|41693957|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|105|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|21|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|85|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|98|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|97|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|103|209926607|Male|Germ Cell Tumors|2009-2013|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|521|209926607|Male|Germ Cell Tumors|2009-2013|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42551070|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|112|42551070|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42005181|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|41820286|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|108|41820286|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|23|41693957|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|105|41693957|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|65|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Glioblastoma|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|397|209926607|Male|Glioblastoma|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42551070|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42005181|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41820286|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|41693957|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|230|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|219|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|238|42158997|Male|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|239|42367071|Male|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|267|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|268|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|70|209926607|Male|Glioma malignant, NOS|2009-2013|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|1318|209926607|Male|Glioma malignant, NOS|2009-2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42551070|Male|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|260|42005181|Male|Glioma malignant, NOS|2011|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|18|41820286|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|264|41820286|Male|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|20|41693957|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.5|0.7|0.6|Malignant|253|41693957|Male|Glioma malignant, NOS|2013|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|87|209926607|Male|Hemangioblastoma|2009-2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|209926607|Male|Hemangioblastoma|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|42005181|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42005181|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41820286|Male|Hemangioblastoma|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41820286|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41693957|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41693957|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|31|42158997|Male|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|274|209926607|Male|Hemangioma|2009-2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|209926607|Male|Hemangioma|2009-2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|48|42551070|Male|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42551070|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42005181|Male|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42005181|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41820286|Male|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41820286|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|41693957|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41693957|Male|Hemangioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Local Extensions from Regional Tumors|2009-2013|~|~|~
0-19|~|~|~|Malignant|~|209926607|Male|Local Extensions from Regional Tumors|2009-2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42005181|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|41820286|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Lymphomas and Hematopoietic Neoplasms|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|38|209926607|Male|Lymphomas and Hematopoietic Neoplasms|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42005181|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|41820286|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|49|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|284|209926607|Male|Meningioma|2009-2013|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|18|209926607|Male|Meningioma|2009-2013|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|53|42551070|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42551070|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|64|42005181|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42005181|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|41820286|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41820286|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|41693957|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41693957|Male|Meningioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Mixed glioma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|64|209926607|Male|Mixed glioma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42551070|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42005181|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Mixed glioma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|41820286|Male|Mixed glioma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Mixed glioma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Neoplasm, unspecified|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|49|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|61|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|46|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|87|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|343|209926607|Male|Neoplasm, unspecified|2009-2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|100|209926607|Male|Neoplasm, unspecified|2009-2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|77|42551070|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42551070|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|66|42005181|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|42005181|Male|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|54|41820286|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|27|41820286|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|59|41693957|Male|Neoplasm, unspecified|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|41693957|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|123|41889233|Male|Nerve sheath, benign and malignant|2004|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|669|209926607|Male|Nerve sheath, benign and malignant|2009-2013|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|209926607|Male|Nerve sheath, benign and malignant|2009-2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|42551070|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551070|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|125|42005181|Male|Nerve sheath, benign and malignant|2011|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42005181|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|41820286|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41820286|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|41693957|Male|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41693957|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Neuroepithelial|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|209926607|Male|Neuroepithelial|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42005181|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|41820286|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Neuroepithelial|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|156|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|170|42367071|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|170|42541971|Male|Neuronal/glial, neuronal|2008|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|29|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|884|209926607|Male|Neuronal/glial, neuronal|2009-2013|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|90|209926607|Male|Neuronal/glial, neuronal|2009-2013|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|170|42551070|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42551070|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|181|42005181|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|19|42005181|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|197|41820286|Male|Neuronal/glial, neuronal|2012|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|18|41820286|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|178|41693957|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|21|41693957|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|31|42541971|Male|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Oligodendroglioma|2009-2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|105|209926607|Male|Oligodendroglioma|2009-2013|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42551070|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42005181|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41820286|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41693957|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|148|209926607|Male|Other mesenchymal|2009-2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|38|209926607|Male|Other mesenchymal|2009-2013|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|42551070|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551070|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|42005181|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42005181|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|41820286|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41820286|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41693957|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41693957|Male|Other mesenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|368|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|344|42006384|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|355|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|346|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|385|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|358|42609915|Male|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Pilocytic astrocytoma|2009-2013|~|~|~
0-19|0.9|1.0|0.9|Malignant|1902|209926607|Male|Pilocytic astrocytoma|2009-2013|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|0.9|0.9|Malignant|363|42551070|Male|Pilocytic astrocytoma|2010|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|378|42005181|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|408|41820286|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|402|41693957|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|209926607|Male|Pineal parenchymal|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|78|209926607|Male|Pineal parenchymal|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42551070|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42551070|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42005181|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42005181|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41820286|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41820286|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41693957|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|41693957|Male|Pineal parenchymal|2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41889233|Male|Pituitary|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|125|42541971|Male|Pituitary|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42609915|Male|Pituitary|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|705|209926607|Male|Pituitary|2009-2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|209926607|Male|Pituitary|2009-2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|128|42551070|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551070|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|138|42005181|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42005181|Male|Pituitary|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|158|41820286|Male|Pituitary|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41820286|Male|Pituitary|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|41693957|Male|Pituitary|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41693957|Male|Pituitary|2013|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|665|41889233|Male|Total|2004|1.5|1.7|1.6
0-19|3.4|3.8|3.6|Malignant|1493|41889233|Male|Total|2004|3.4|3.7|3.6
0-19|1.7|1.9|1.8|Benign/Borderline|764|42006384|Male|Total|2005|1.7|2.0|1.8
0-19|3.2|3.6|3.4|Malignant|1412|42006384|Male|Total|2005|3.2|3.5|3.4
0-19|1.7|2.0|1.8|Benign/Borderline|780|42158997|Male|Total|2006|1.7|2.0|1.9
0-19|3.4|3.7|3.6|Malignant|1494|42158997|Male|Total|2006|3.4|3.7|3.5
0-19|1.8|2.0|1.9|Benign/Borderline|818|42367071|Male|Total|2007|1.8|2.1|1.9
0-19|3.4|3.8|3.6|Malignant|1506|42367071|Male|Total|2007|3.4|3.7|3.6
0-19|1.8|2.0|1.9|Benign/Borderline|811|42541971|Male|Total|2008|1.8|2.0|1.9
0-19|3.5|3.9|3.7|Malignant|1582|42541971|Male|Total|2008|3.5|3.9|3.7
0-19|2.0|2.2|2.1|Benign/Borderline|905|42609915|Male|Total|2009|2.0|2.3|2.1
0-19|3.4|3.8|3.6|Malignant|1540|42609915|Male|Total|2009|3.4|3.8|3.6
0-19|2.0|2.2|2.1|Benign/Borderline|4419|209926607|Male|Total|2009-2013|2.0|2.2|2.1
0-19|3.6|3.8|3.7|Malignant|7697|209926607|Male|Total|2009-2013|3.6|3.7|3.7
0-19|1.9|2.1|2.0|Benign/Borderline|850|42551070|Male|Total|2010|1.9|2.1|2.0
0-19|3.5|3.9|3.7|Malignant|1573|42551070|Male|Total|2010|3.5|3.9|3.7
0-19|1.9|2.2|2.1|Benign/Borderline|878|42005181|Male|Total|2011|2.0|2.2|2.1
0-19|3.5|3.8|3.6|Malignant|1531|42005181|Male|Total|2011|3.5|3.8|3.6
0-19|2.1|2.4|2.2|Benign/Borderline|931|41820286|Male|Total|2012|2.1|2.4|2.2
0-19|3.6|3.9|3.7|Malignant|1564|41820286|Male|Total|2012|3.6|3.9|3.7
0-19|1.9|2.2|2.1|Benign/Borderline|858|41693957|Male|Total|2013|1.9|2.2|2.1
0-19|3.4|3.8|3.6|Malignant|1509|41693957|Male|Total|2013|3.4|3.8|3.6
0-19|0.2|0.4|0.3|Benign/Borderline|123|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|670|209926607|Male|Tumors of Cranial and Spinal Nerves|2009-2013|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|209926607|Male|Tumors of Cranial and Spinal Nerves|2009-2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|42551070|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551070|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|125|42005181|Male|Tumors of Cranial and Spinal Nerves|2011|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42005181|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|41820286|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41820286|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|41693957|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41693957|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|227|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.4|3.3|Malignant|1354|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|258|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.2|3.1|Malignant|1281|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|256|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1344|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|262|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1360|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.0|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|268|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.2|3.5|3.4|Malignant|1419|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.5|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|267|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1396|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|1412|209926607|Male|Tumors of Neuroepthelial Tissue|2009-2013|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|6950|209926607|Male|Tumors of Neuroepthelial Tissue|2009-2013|3.2|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|276|42551070|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.2|3.5|3.3|Malignant|1418|42551070|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|287|42005181|Male|Tumors of Neuroepthelial Tissue|2011|0.6|0.8|0.7
0-19|3.2|3.5|3.3|Malignant|1397|42005181|Male|Tumors of Neuroepthelial Tissue|2011|3.2|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|300|41820286|Male|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.2|3.5|3.4|Malignant|1400|41820286|Male|Tumors of Neuroepthelial Tissue|2012|3.2|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|283|41693957|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.1|3.4|3.3|Malignant|1357|41693957|Male|Tumors of Neuroepthelial Tissue|2013|3.1|3.4|3.3
0-19|0.3|0.5|0.4|Benign/Borderline|166|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|209|42006384|Male|Tumors of Sellar Region|2005|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|168|42158997|Male|Tumors of Sellar Region|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|199|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|218|42541971|Male|Tumors of Sellar Region|2008|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|229|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.5|0.5|0.5|Benign/Borderline|1097|209926607|Male|Tumors of Sellar Region|2009-2013|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|209926607|Male|Tumors of Sellar Region|2009-2013|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|209|42551070|Male|Tumors of Sellar Region|2010|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42551070|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|207|42005181|Male|Tumors of Sellar Region|2011|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42005181|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|236|41820286|Male|Tumors of Sellar Region|2012|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|41820286|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|217|41693957|Male|Tumors of Sellar Region|2013|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|41693957|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42006384|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|42367071|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|87|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|519|209926607|Male|Tumors of the Meninges|2009-2013|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|57|209926607|Male|Tumors of the Meninges|2009-2013|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|90|42551070|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42551070|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|42005181|Male|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42005181|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|120|41820286|Male|Tumors of the Meninges|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41820286|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|41693957|Male|Tumors of the Meninges|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41693957|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unclassified Tumors|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|80|42158997|Male|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|113|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|27|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|82|42541971|Male|Unclassified Tumors|2008|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|145|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|618|209926607|Male|Unclassified Tumors|2009-2013|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|107|209926607|Male|Unclassified Tumors|2009-2013|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|126|42551070|Male|Unclassified Tumors|2010|0.2|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|18|42551070|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|127|42005181|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|42005181|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|112|41820286|Male|Unclassified Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|30|41820286|Male|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|108|41693957|Male|Unclassified Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|41693957|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|39|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|157|209926607|Male|Unique astrocytoma variants|2009-2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|113|209926607|Male|Unique astrocytoma variants|2009-2013|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|42551070|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551070|Male|Unique astrocytoma variants|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|42005181|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42005181|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|29|41820286|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|41820286|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|30|41693957|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|41693957|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|35|410461980|Male and Female|All other|2009-2013|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|60|410461980|Male and Female|All other|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|83185431|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82115497|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|81779507|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|81571493|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|65|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|84|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|69|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Anaplastic astrocytoma|2009-2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|381|410461980|Male and Female|Anaplastic astrocytoma|2009-2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|82|83185431|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|82115497|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|81779507|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|91|81571493|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Anaplastic oligodendroglioma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|410461980|Male and Female|Anaplastic oligodendroglioma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83185431|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82115497|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|81779507|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|81571493|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|199|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|190|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|180|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|201|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Astrocytoma, NOS|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|936|410461980|Male and Female|Astrocytoma, NOS|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|83185431|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82115497|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|164|81779507|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|178|81571493|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|53|82005260|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|78|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|305|410461980|Male and Female|Choroid plexus|2009-2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|84|410461980|Male and Female|Choroid plexus|2009-2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|83185431|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|83185431|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|82115497|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82115497|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|81779507|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|81779507|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|81571493|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|81571493|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|164|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|167|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|153|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|179|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|155|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|171|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|816|410461980|Male and Female|Craniopharyngioma|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|410461980|Male and Female|Craniopharyngioma|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|171|83185431|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83185431|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|152|82115497|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82115497|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|81779507|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81779507|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|166|81571493|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81571493|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|40|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Diffuse astrocytoma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|142|410461980|Male and Female|Diffuse astrocytoma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|83185431|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82115497|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|81779507|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|81571493|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|508|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|496|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|517|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|548|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|513|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Embryonal/primitive/medulloblastoma|2009-2013|~|~|~
0-19|0.6|0.6|0.6|Malignant|2397|410461980|Male and Female|Embryonal/primitive/medulloblastoma|2009-2013|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|488|83185431|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|490|82115497|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|465|81779507|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|449|81571493|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|179|410461980|Male and Female|Ependymoma variants|2009-2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|410461980|Male and Female|Ependymoma variants|2009-2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83185431|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83185431|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|82115497|Male and Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82115497|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|81779507|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81779507|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|81571493|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81571493|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|198|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|216|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|207|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Ependymoma/anaplastic ependymoma|2009-2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|1001|410461980|Male and Female|Ependymoma/anaplastic ependymoma|2009-2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|210|83185431|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|210|82115497|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|199|81779507|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|193|81571493|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|30|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|147|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|144|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|139|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|194|410461980|Male and Female|Germ Cell Tumors|2009-2013|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|719|410461980|Male and Female|Germ Cell Tumors|2009-2013|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|83185431|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|165|83185431|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82115497|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|137|82115497|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|81779507|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|129|81779507|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|41|81571493|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|149|81571493|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|99|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Glioblastoma|2009-2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|695|410461980|Male and Female|Glioblastoma|2009-2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83185431|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|151|82115497|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|149|81779507|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|157|81571493|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|450|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|483|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|499|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|540|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|563|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|142|410461980|Male and Female|Glioma malignant, NOS|2009-2013|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|2635|410461980|Male and Female|Glioma malignant, NOS|2009-2013|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|23|83185431|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|526|83185431|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|35|82115497|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|559|82115497|Male and Female|Glioma malignant, NOS|2011|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|39|81779507|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|476|81779507|Male and Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|34|81571493|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|512|81571493|Male and Female|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|28|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|155|410461980|Male and Female|Hemangioblastoma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|410461980|Male and Female|Hemangioblastoma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|83185431|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83185431|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82115497|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82115497|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|81779507|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81779507|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|81571493|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81571493|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|42|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|64|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|76|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|74|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|107|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|538|410461980|Male and Female|Hemangioma|2009-2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|410461980|Male and Female|Hemangioma|2009-2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|86|83185431|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83185431|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|122|82115497|Male and Female|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82115497|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|120|81779507|Male and Female|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81779507|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|103|81571493|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81571493|Male and Female|Hemangioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Local Extensions from Regional Tumors|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|410461980|Male and Female|Local Extensions from Regional Tumors|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83185431|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82115497|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|81779507|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|81571493|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|66|410461980|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83185431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82115497|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|81779507|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|81571493|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|124|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|99|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|103|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|116|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|117|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|592|410461980|Male and Female|Meningioma|2009-2013|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|33|410461980|Male and Female|Meningioma|2009-2013|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|112|83185431|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83185431|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82115497|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82115497|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|81779507|Male and Female|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81779507|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|118|81571493|Male and Female|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81571493|Male and Female|Meningioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Mixed glioma|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|128|410461980|Male and Female|Mixed glioma|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|83185431|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82115497|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|81779507|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|81571493|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|108|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|35|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|98|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|109|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|39|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|120|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|145|83280391|Male and Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|682|410461980|Male and Female|Neoplasm, unspecified|2009-2013|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|191|410461980|Male and Female|Neoplasm, unspecified|2009-2013|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|165|83185431|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83185431|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|132|82115497|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82115497|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|117|81779507|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|51|81779507|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|124|81571493|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|81571493|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|233|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|274|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|313|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|266|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|291|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1285|410461980|Male and Female|Nerve sheath, benign and malignant|2009-2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|21|410461980|Male and Female|Nerve sheath, benign and malignant|2009-2013|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|245|83185431|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|83185431|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|242|82115497|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82115497|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|81779507|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|81779507|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|245|81571493|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81571493|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Neuroepithelial|2009-2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|47|410461980|Male and Female|Neuroepithelial|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83185431|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82115497|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|81779507|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|81571493|Male and Female|Neuroepithelial|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|294|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|277|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|307|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|61|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|303|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|55|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|290|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|34|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|1592|410461980|Male and Female|Neuronal/glial, neuronal|2009-2013|0.4|0.4|0.4
0-19|0.0|0.0|0.0|Malignant|176|410461980|Male and Female|Neuronal/glial, neuronal|2009-2013|0.0|0.0|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|312|83185431|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83185431|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|322|82115497|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|33|82115497|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|344|81779507|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|34|81779507|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|325|81571493|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|41|81571493|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|42|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Oligodendroglioma|2009-2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|200|410461980|Male and Female|Oligodendroglioma|2009-2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83185431|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82115497|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|46|81779507|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81571493|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82749431|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|46|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|305|410461980|Male and Female|Other mesenchymal|2009-2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|66|410461980|Male and Female|Other mesenchymal|2009-2013|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|46|83185431|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83185431|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|56|82115497|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82115497|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|89|81779507|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|81779507|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|81571493|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81571493|Male and Female|Other mesenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|698|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|660|82005260|Male and Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|664|82324418|Male and Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|677|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|714|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|701|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|410461980|Male and Female|Pilocytic astrocytoma|2009-2013|~|~|~
0-19|0.9|0.9|0.9|Malignant|3653|410461980|Male and Female|Pilocytic astrocytoma|2009-2013|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|737|83185431|Male and Female|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|0.9|0.9|Malignant|720|82115497|Male and Female|Pilocytic astrocytoma|2011|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|762|81779507|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|0.9|Malignant|745|81571493|Male and Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|37|410461980|Male and Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|146|410461980|Male and Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185431|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83185431|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115497|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82115497|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81779507|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|81779507|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81571493|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|81571493|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|335|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|410|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|413|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.5|0.5|Benign/Borderline|427|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|481|83118264|Male and Female|Pituitary|2008|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|502|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|2648|410461980|Male and Female|Pituitary|2009-2013|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|410461980|Male and Female|Pituitary|2009-2013|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|541|83185431|Male and Female|Pituitary|2010|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83185431|Male and Female|Pituitary|2010|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|530|82115497|Male and Female|Pituitary|2011|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|82115497|Male and Female|Pituitary|2011|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|563|81779507|Male and Female|Pituitary|2012|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|81779507|Male and Female|Pituitary|2012|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|518|81571493|Male and Female|Pituitary|2013|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81571493|Male and Female|Pituitary|2013|~|~|~
0-19|1.6|1.8|1.7|Benign/Borderline|1420|81754354|Male and Female|Total|2004|1.6|1.8|1.7
0-19|3.3|3.6|3.4|Malignant|2796|81754354|Male and Female|Total|2004|3.3|3.5|3.4
0-19|1.9|2.1|2.0|Benign/Borderline|1674|82005260|Male and Female|Total|2005|1.9|2.1|2.0
0-19|3.1|3.4|3.2|Malignant|2633|82005260|Male and Female|Total|2005|3.1|3.3|3.2
0-19|1.9|2.1|2.0|Benign/Borderline|1697|82324418|Male and Female|Total|2006|2.0|2.2|2.1
0-19|3.2|3.4|3.3|Malignant|2709|82324418|Male and Female|Total|2006|3.2|3.4|3.3
0-19|2.0|2.2|2.1|Benign/Borderline|1748|82749431|Male and Female|Total|2007|2.0|2.2|2.1
0-19|3.3|3.5|3.4|Malignant|2792|82749431|Male and Female|Total|2007|3.3|3.5|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1799|83118264|Male and Female|Total|2008|2.1|2.3|2.2
0-19|3.3|3.6|3.4|Malignant|2852|83118264|Male and Female|Total|2008|3.3|3.6|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1921|83280391|Male and Female|Total|2009|2.2|2.4|2.3
0-19|3.3|3.5|3.4|Malignant|2817|83280391|Male and Female|Total|2009|3.3|3.5|3.4
0-19|2.3|2.4|2.4|Benign/Borderline|9770|410461980|Male and Female|Total|2009-2013|2.3|2.4|2.4
0-19|3.4|3.5|3.4|Malignant|13985|410461980|Male and Female|Total|2009-2013|3.4|3.5|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1932|83185431|Male and Female|Total|2010|2.2|2.4|2.3
0-19|3.3|3.6|3.4|Malignant|2839|83185431|Male and Female|Total|2010|3.3|3.5|3.4
0-19|2.2|2.5|2.4|Benign/Borderline|1949|82115497|Male and Female|Total|2011|2.3|2.5|2.4
0-19|3.3|3.6|3.5|Malignant|2842|82115497|Male and Female|Total|2011|3.3|3.6|3.5
0-19|2.4|2.6|2.5|Benign/Borderline|2039|81779507|Male and Female|Total|2012|2.4|2.6|2.5
0-19|3.2|3.5|3.4|Malignant|2753|81779507|Male and Female|Total|2012|3.2|3.5|3.4
0-19|2.3|2.5|2.4|Benign/Borderline|1940|81571493|Male and Female|Total|2013|2.3|2.5|2.4
0-19|3.3|3.5|3.4|Malignant|2773|81571493|Male and Female|Total|2013|3.3|3.5|3.4
0-19|0.3|0.3|0.3|Benign/Borderline|233|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|274|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|313|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|266|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|291|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1287|410461980|Male and Female|Tumors of Cranial and Spinal Nerves|2009-2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|21|410461980|Male and Female|Tumors of Cranial and Spinal Nerves|2009-2013|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|245|83185431|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|83185431|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|243|82115497|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82115497|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|81779507|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|81779507|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|246|81571493|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81571493|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|415|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.1|Malignant|2559|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|448|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
0-19|2.8|3.1|3.0|Malignant|2412|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.8|3.1|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|454|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|2491|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|489|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|3.0|3.3|3.1|Malignant|2581|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|490|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|3.1|3.3|3.2|Malignant|2636|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|470|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2592|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.2|3.1
0-19|0.6|0.6|0.6|Benign/Borderline|2550|410461980|Male and Female|Tumors of Neuroepthelial Tissue|2009-2013|0.6|0.6|0.6
0-19|3.1|3.2|3.1|Malignant|12851|410461980|Male and Female|Tumors of Neuroepthelial Tissue|2009-2013|3.1|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|502|83185431|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|2605|83185431|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|517|82115497|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2629|82115497|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|542|81779507|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.7
0-19|3.0|3.2|3.1|Malignant|2526|81779507|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.0|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|521|81571493|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.6
0-19|3.0|3.2|3.1|Malignant|2535|81571493|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.0|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|499|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|577|82005260|Male and Female|Tumors of Sellar Region|2005|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|566|82324418|Male and Female|Tumors of Sellar Region|2006|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|606|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|636|83118264|Male and Female|Tumors of Sellar Region|2008|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|673|83280391|Male and Female|Tumors of Sellar Region|2009|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|3464|410461980|Male and Female|Tumors of Sellar Region|2009-2013|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|410461980|Male and Female|Tumors of Sellar Region|2009-2013|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|712|83185431|Male and Female|Tumors of Sellar Region|2010|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|83185431|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|682|82115497|Male and Female|Tumors of Sellar Region|2011|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82115497|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|719|81779507|Male and Female|Tumors of Sellar Region|2012|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|81779507|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|684|81571493|Male and Female|Tumors of Sellar Region|2013|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|81571493|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|145|81754354|Male and Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|19|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|190|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|167|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|173|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|191|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|1052|410461980|Male and Female|Tumors of the Meninges|2009-2013|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|101|410461980|Male and Female|Tumors of the Meninges|2009-2013|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|182|83185431|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83185431|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|218|82115497|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82115497|Male and Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|243|81779507|Male and Female|Tumors of the Meninges|2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|20|81779507|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|219|81571493|Male and Female|Tumors of the Meninges|2013|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|81571493|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|98|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|150|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|162|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|185|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|44|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|194|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|41|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1222|410461980|Male and Female|Unclassified Tumors|2009-2013|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|201|410461980|Male and Female|Unclassified Tumors|2009-2013|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|83185431|Male and Female|Unclassified Tumors|2010|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|28|83185431|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|254|82115497|Male and Female|Unclassified Tumors|2011|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|37|82115497|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|237|81779507|Male and Female|Unclassified Tumors|2012|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|54|81779507|Male and Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|228|81571493|Male and Female|Unclassified Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|42|81571493|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|49|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|48|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|55|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|60|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|70|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|282|410461980|Male and Female|Unique astrocytoma variants|2009-2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|196|410461980|Male and Female|Unique astrocytoma variants|2009-2013|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|51|83185431|Male and Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|83185431|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|47|82115497|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|47|82115497|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|58|81779507|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|81779507|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|56|81571493|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|40|81571493|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|79|584684605|Female|All other|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|73|584684605|Female|All other|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|116623212|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|116623212|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116968930|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|116968930|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|118257088|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|118257088|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|119491470|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|21|119491470|Female|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|565|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|508|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|530|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|498|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|500|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|584684605|Female|Anaplastic astrocytoma|2009-2013|~|~|~
20+|0.4|0.5|0.5|Malignant|2814|584684605|Female|Anaplastic astrocytoma|2009-2013|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|116623212|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|565|116623212|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|116968930|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|559|116968930|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|118257088|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|576|118257088|Female|Anaplastic astrocytoma|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119491470|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.5|0.5|Malignant|623|119491470|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|181|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|166|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|138|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|154|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|168|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|142|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|584684605|Female|Anaplastic oligodendroglioma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|720|584684605|Female|Anaplastic oligodendroglioma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116623212|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|131|116623212|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116968930|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|147|116968930|Female|Anaplastic oligodendroglioma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118257088|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|161|118257088|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119491470|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|139|119491470|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|571|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|558|110320645|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|532|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|532|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|492|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|483|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|584684605|Female|Astrocytoma, NOS|2009-2013|~|~|~
20+|0.4|0.4|0.4|Malignant|2318|584684605|Female|Astrocytoma, NOS|2009-2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116623212|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|475|116623212|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116968930|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|453|116968930|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|118257088|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|481|118257088|Female|Astrocytoma, NOS|2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119491470|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|431|119491470|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|41|111567226|Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|46|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|44|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|224|584684605|Female|Choroid plexus|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|584684605|Female|Choroid plexus|2009-2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|48|116623212|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116623212|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|116968930|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116968930|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|118257088|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|118257088|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|46|119491470|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|119491470|Female|Choroid plexus|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|183|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1110|584684605|Female|Craniopharyngioma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|584684605|Female|Craniopharyngioma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|232|116623212|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116623212|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|213|116968930|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116968930|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|212|118257088|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118257088|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|229|119491470|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119491470|Female|Craniopharyngioma|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|132|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|133|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|584684605|Female|Diffuse astrocytoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|594|584684605|Female|Diffuse astrocytoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116623212|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|116623212|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116968930|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|111|116968930|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118257088|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|93|118257088|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119491470|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|68|119491470|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|84|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|90|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|88|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|106|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|584684605|Female|Embryonal/primitive/medulloblastoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|413|584684605|Female|Embryonal/primitive/medulloblastoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116623212|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|73|116623212|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116968930|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|68|116968930|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118257088|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|81|118257088|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119491470|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|86|119491470|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|147|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|588|584684605|Female|Ependymoma variants|2009-2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|584684605|Female|Ependymoma variants|2009-2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|116623212|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116623212|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|117|116968930|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116968930|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|126|118257088|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|118257088|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|114|119491470|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119491470|Female|Ependymoma variants|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|291|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|300|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|291|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|294|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|311|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|338|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|29|584684605|Female|Ependymoma/anaplastic ependymoma|2009-2013|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|1478|584684605|Female|Ependymoma/anaplastic ependymoma|2009-2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116623212|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|292|116623212|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116968930|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|296|116968930|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118257088|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|299|118257088|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119491470|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|260|119491470|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|40|115293599|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|148|584684605|Female|Germ Cell Tumors|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|39|584684605|Female|Germ Cell Tumors|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|116623212|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116623212|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116968930|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116968930|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|118257088|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|118257088|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|119491470|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119491470|Female|Germ Cell Tumors|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4090|109112165|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4149|110320645|Female|Glioblastoma|2005|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.4|3.7|3.5|Malignant|4280|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4365|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4398|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4460|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|584684605|Female|Glioblastoma|2009-2013|~|~|~
20+|3.5|3.5|3.5|Malignant|23134|584684605|Female|Glioblastoma|2009-2013|3.9|4.0|4.0
20+|~|~|~|Benign/Borderline|~|116623212|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4596|116623212|Female|Glioblastoma|2010|3.8|4.1|3.9
20+|~|~|~|Benign/Borderline|~|116968930|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4544|116968930|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|118257088|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4791|118257088|Female|Glioblastoma|2012|3.9|4.2|4.1
20+|~|~|~|Benign/Borderline|~|119491470|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4793|119491470|Female|Glioblastoma|2013|3.9|4.1|4.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|419|109112165|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|389|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|393|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|404|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|432|114027722|Female|Glioma malignant, NOS|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|509|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|57|584684605|Female|Glioma malignant, NOS|2009-2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|2180|584684605|Female|Glioma malignant, NOS|2009-2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116623212|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|404|116623212|Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116968930|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|429|116968930|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|118257088|Female|Glioma malignant, NOS|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|409|118257088|Female|Glioma malignant, NOS|2012|0.3|0.4|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|119491470|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|435|119491470|Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|203|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|213|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1155|584684605|Female|Hemangioblastoma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|584684605|Female|Hemangioblastoma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|116623212|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116623212|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|116968930|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116968930|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|245|118257088|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118257088|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|119491470|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119491470|Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|269|110320645|Female|Hemangioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|298|111567226|Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|355|112783993|Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|442|114027722|Female|Hemangioma|2008|0.4|0.4|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|489|115293599|Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|3094|584684605|Female|Hemangioma|2009-2013|0.5|0.5|0.5
20+|~|~|~|Malignant|~|584684605|Female|Hemangioma|2009-2013|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|624|116623212|Female|Hemangioma|2010|0.5|0.6|0.5
20+|~|~|~|Malignant|~|116623212|Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|680|116968930|Female|Hemangioma|2011|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116968930|Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|663|118257088|Female|Hemangioma|2012|0.5|0.6|0.6
20+|~|~|~|Malignant|~|118257088|Female|Hemangioma|2012|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|640|119491470|Female|Hemangioma|2013|0.5|0.6|0.5
20+|~|~|~|Malignant|~|119491470|Female|Hemangioma|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|584684605|Female|Local Extensions from Regional Tumors|2009-2013|~|~|~
20+|0.0|0.0|0.0|Malignant|104|584684605|Female|Local Extensions from Regional Tumors|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116623212|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|22|116623212|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116968930|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|116968930|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118257088|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|118257088|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119491470|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|17|119491470|Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|592|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|660|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|671|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|636|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|699|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|662|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|584684605|Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|~|~|~
20+|0.5|0.6|0.5|Malignant|3524|584684605|Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116623212|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|747|116623212|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|116968930|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|710|116968930|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|118257088|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|691|118257088|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|119491470|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|725|119491470|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|11.7|12.1|11.9|Benign/Borderline|13814|109112165|Female|Meningioma|2004|12.5|12.9|12.7
20+|0.2|0.3|0.2|Malignant|273|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|13.1|13.6|13.3|Benign/Borderline|15790|110320645|Female|Meningioma|2005|14.1|14.5|14.3
20+|0.2|0.3|0.2|Malignant|279|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|13.7|14.2|13.9|Benign/Borderline|16768|111567226|Female|Meningioma|2006|14.8|15.3|15.0
20+|0.2|0.2|0.2|Malignant|256|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.1|14.5|14.3|Benign/Borderline|17517|112783993|Female|Meningioma|2007|15.3|15.8|15.5
20+|0.2|0.2|0.2|Malignant|267|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|14.7|15.2|15.0|Benign/Borderline|18634|114027722|Female|Meningioma|2008|16.1|16.6|16.3
20+|0.1|0.2|0.2|Malignant|215|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|15.6|16.1|15.8|Benign/Borderline|20069|115293599|Female|Meningioma|2009|17.2|17.6|17.4
20+|0.1|0.2|0.2|Malignant|201|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|15.1|15.3|15.2|Benign/Borderline|98374|584684605|Female|Meningioma|2009-2013|16.7|16.9|16.8
20+|0.1|0.2|0.2|Malignant|990|584684605|Female|Meningioma|2009-2013|0.2|0.2|0.2
20+|14.9|15.4|15.1|Benign/Borderline|19476|116623212|Female|Meningioma|2010|16.5|16.9|16.7
20+|0.1|0.2|0.2|Malignant|203|116623212|Female|Meningioma|2010|0.2|0.2|0.2
20+|14.9|15.4|15.1|Benign/Borderline|19591|116968930|Female|Meningioma|2011|16.5|17.0|16.7
20+|0.1|0.2|0.1|Malignant|180|116968930|Female|Meningioma|2011|0.1|0.2|0.2
20+|14.9|15.3|15.1|Benign/Borderline|19855|118257088|Female|Meningioma|2012|16.6|17.0|16.8
20+|0.1|0.2|0.2|Malignant|196|118257088|Female|Meningioma|2012|0.1|0.2|0.2
20+|14.5|14.9|14.7|Benign/Borderline|19621|119491470|Female|Meningioma|2013|16.2|16.7|16.4
20+|0.1|0.2|0.2|Malignant|212|119491470|Female|Meningioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|195|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|239|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|272|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.2|Malignant|240|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|262|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|280|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|584684605|Female|Mixed glioma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Malignant|1290|584684605|Female|Mixed glioma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|116623212|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|268|116623212|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116968930|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|268|116968930|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|118257088|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|233|118257088|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|119491470|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|243|119491470|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|0.5|0.6|0.6|Benign/Borderline|682|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|702|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|863|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|728|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|787|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|727|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|823|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|658|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|819|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|759|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|901|115293599|Female|Neoplasm, unspecified|2009|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|785|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Benign/Borderline|4012|584684605|Female|Neoplasm, unspecified|2009-2013|0.7|0.7|0.7
20+|0.5|0.5|0.5|Malignant|3312|584684605|Female|Neoplasm, unspecified|2009-2013|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|801|116623212|Female|Neoplasm, unspecified|2010|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|648|116623212|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|792|116968930|Female|Neoplasm, unspecified|2011|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|633|116968930|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|799|118257088|Female|Neoplasm, unspecified|2012|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|638|118257088|Female|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|731|119491470|Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.4|0.5|0.4|Malignant|621|119491470|Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2501|109112165|Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2750|110320645|Female|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2878|111567226|Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2867|112783993|Female|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2953|114027722|Female|Nerve sheath, benign and malignant|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|3100|115293599|Female|Nerve sheath, benign and malignant|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|15318|584684605|Female|Nerve sheath, benign and malignant|2009-2013|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|106|584684605|Female|Nerve sheath, benign and malignant|2009-2013|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2867|116623212|Female|Nerve sheath, benign and malignant|2010|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|116623212|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3034|116968930|Female|Nerve sheath, benign and malignant|2011|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|116968930|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3165|118257088|Female|Nerve sheath, benign and malignant|2012|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|25|118257088|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3177|119491470|Female|Nerve sheath, benign and malignant|2013|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|23|119491470|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|584684605|Female|Neuroepithelial|2009-2013|~|~|~
20+|0.0|0.0|0.0|Malignant|116|584684605|Female|Neuroepithelial|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116623212|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116623212|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116968930|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|116968930|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118257088|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|118257088|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119491470|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119491470|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|153|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|200|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|219|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1070|584684605|Female|Neuronal/glial, neuronal|2009-2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|90|584684605|Female|Neuronal/glial, neuronal|2009-2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|244|116623212|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|116623212|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|233|116968930|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|116968930|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|204|118257088|Female|Neuronal/glial, neuronal|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|118257088|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|172|119491470|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|119491470|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|351|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|351|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|374|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|366|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|357|114027722|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|355|115293599|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|584684605|Female|Oligodendroglioma|2009-2013|~|~|~
20+|0.3|0.3|0.3|Malignant|1597|584684605|Female|Oligodendroglioma|2009-2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116623212|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|325|116623212|Female|Oligodendroglioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116968930|Female|Oligodendroglioma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|306|116968930|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118257088|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|283|118257088|Female|Oligodendroglioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|119491470|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|332|119491470|Female|Oligodendroglioma|2013|0.2|0.3|0.3
20+|0.0|0.1|0.1|Benign/Borderline|67|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|84|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|85|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|52|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|468|584684605|Female|Other mesenchymal|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|162|584684605|Female|Other mesenchymal|2009-2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|116623212|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|116623212|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|85|116968930|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|116968930|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|118257088|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|118257088|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|119491470|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|119491470|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|149|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|148|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|159|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|134|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|584684605|Female|Pilocytic astrocytoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|723|584684605|Female|Pilocytic astrocytoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116623212|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|166|116623212|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116968930|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|157|116968930|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|118257088|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|118|118257088|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119491470|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|151|119491470|Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|42|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|192|584684605|Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|127|584684605|Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|116623212|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116623212|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|42|116968930|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|116968930|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|118257088|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|118257088|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|48|119491470|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|32|119491470|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|3.5|3.7|3.6|Benign/Borderline|3903|109112165|Female|Pituitary|2004|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|4532|110320645|Female|Pituitary|2005|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.4|4.7|4.5|Benign/Borderline|5040|111567226|Female|Pituitary|2006|4.4|4.6|4.5
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.5|4.7|4.6|Benign/Borderline|5139|112783993|Female|Pituitary|2007|4.4|4.7|4.6
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|4.7|5.0|4.9|Benign/Borderline|5489|114027722|Female|Pituitary|2008|4.7|4.9|4.8
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.2|5.5|5.3|Benign/Borderline|6084|115293599|Female|Pituitary|2009|5.1|5.4|5.3
20+|~|~|~|Malignant|~|115293599|Female|Pituitary|2009|~|~|~
20+|5.2|5.3|5.2|Benign/Borderline|30197|584684605|Female|Pituitary|2009-2013|5.1|5.2|5.2
20+|0.0|0.0|0.0|Malignant|69|584684605|Female|Pituitary|2009-2013|0.0|0.0|0.0
20+|5.0|5.3|5.2|Benign/Borderline|5945|116623212|Female|Pituitary|2010|5.0|5.2|5.1
20+|~|~|~|Malignant|~|116623212|Female|Pituitary|2010|~|~|~
20+|5.1|5.4|5.3|Benign/Borderline|6043|116968930|Female|Pituitary|2011|5.0|5.3|5.2
20+|~|~|~|Malignant|~|116968930|Female|Pituitary|2011|~|~|~
20+|5.2|5.5|5.4|Benign/Borderline|6234|118257088|Female|Pituitary|2012|5.1|5.4|5.3
20+|~|~|~|Malignant|~|118257088|Female|Pituitary|2012|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|5951|119491470|Female|Pituitary|2013|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|16|119491470|Female|Pituitary|2013|0.0|0.0|0.0
20+|19.0|19.5|19.3|Benign/Borderline|21989|109112165|Female|Total|2004|19.9|20.4|20.2
20+|7.4|7.8|7.6|Malignant|8720|109112165|Female|Total|2004|7.8|8.2|8.0
20+|21.5|22.0|21.7|Benign/Borderline|25171|110320645|Female|Total|2005|22.5|23.1|22.8
20+|7.5|7.8|7.6|Malignant|8893|110320645|Female|Total|2005|7.9|8.2|8.1
20+|22.5|23.1|22.8|Benign/Borderline|26787|111567226|Female|Total|2006|23.7|24.3|24.0
20+|7.4|7.7|7.6|Malignant|8951|111567226|Female|Total|2006|7.9|8.2|8.0
20+|23.0|23.5|23.2|Benign/Borderline|27732|112783993|Female|Total|2007|24.3|24.9|24.6
20+|7.4|7.7|7.6|Malignant|9035|112783993|Female|Total|2007|7.8|8.2|8.0
20+|24.0|24.6|24.3|Benign/Borderline|29417|114027722|Female|Total|2008|25.5|26.1|25.8
20+|7.4|7.7|7.5|Malignant|9189|114027722|Female|Total|2008|7.9|8.2|8.1
20+|25.5|26.1|25.8|Benign/Borderline|31740|115293599|Female|Total|2009|27.2|27.8|27.5
20+|7.3|7.7|7.5|Malignant|9317|115293599|Female|Total|2009|7.9|8.2|8.1
20+|24.8|25.1|25.0|Benign/Borderline|156484|584684605|Female|Total|2009-2013|26.6|26.9|26.8
20+|7.2|7.3|7.2|Malignant|46101|584684605|Female|Total|2009-2013|7.8|8.0|7.9
20+|24.5|25.0|24.7|Benign/Borderline|30830|116623212|Female|Total|2010|26.1|26.7|26.4
20+|7.2|7.5|7.3|Malignant|9256|116623212|Female|Total|2010|7.8|8.1|7.9
20+|24.7|25.3|25.0|Benign/Borderline|31256|116968930|Female|Total|2011|26.4|27.0|26.7
20+|7.0|7.3|7.1|Malignant|9051|116968930|Female|Total|2011|7.6|7.9|7.7
20+|24.8|25.3|25.0|Benign/Borderline|31825|118257088|Female|Total|2012|26.6|27.2|26.9
20+|7.0|7.3|7.2|Malignant|9268|118257088|Female|Total|2012|7.7|8.0|7.8
20+|23.9|24.5|24.2|Benign/Borderline|31180|119491470|Female|Total|2013|25.8|26.4|26.1
20+|6.9|7.2|7.1|Malignant|9323|119491470|Female|Total|2013|7.6|8.0|7.8
20+|2.1|2.3|2.2|Benign/Borderline|2501|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2753|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2879|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2868|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2955|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|3103|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|15327|584684605|Female|Tumors of Cranial and Spinal Nerves|2009-2013|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|106|584684605|Female|Tumors of Cranial and Spinal Nerves|2009-2013|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2870|116623212|Female|Tumors of Cranial and Spinal Nerves|2010|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|116623212|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3036|116968930|Female|Tumors of Cranial and Spinal Nerves|2011|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|116968930|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3165|118257088|Female|Tumors of Cranial and Spinal Nerves|2012|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|25|118257088|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3178|119491470|Female|Tumors of Cranial and Spinal Nerves|2013|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|23|119491470|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|0.3|0.4|0.3|Benign/Borderline|375|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.0|6.3|6.2|Malignant|7039|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|437|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7113|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|472|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7192|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|475|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.3|6.2|Malignant|7356|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|481|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7384|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|502|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7572|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.4|6.7|6.6
20+|0.4|0.5|0.5|Benign/Borderline|2580|584684605|Female|Tumors of Neuroepthelial Tissue|2009-2013|0.4|0.5|0.4
20+|5.9|6.0|6.0|Malignant|37759|584684605|Female|Tumors of Neuroepthelial Tissue|2009-2013|6.4|6.5|6.5
20+|0.4|0.5|0.5|Benign/Borderline|535|116623212|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.0|Malignant|7550|116623212|Female|Tumors of Neuroepthelial Tissue|2010|6.3|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|543|116968930|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.0|5.9|Malignant|7433|116968930|Female|Tumors of Neuroepthelial Tissue|2011|6.2|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|517|118257088|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.4
20+|5.8|6.1|6.0|Malignant|7634|118257088|Female|Tumors of Neuroepthelial Tissue|2012|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|488|119491470|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.4|0.4
20+|5.7|6.0|5.9|Malignant|7658|119491470|Female|Tumors of Neuroepthelial Tissue|2013|6.3|6.6|6.4
20+|3.7|3.9|3.8|Benign/Borderline|4101|109112165|Female|Tumors of Sellar Region|2004|3.6|3.9|3.8
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4715|110320645|Female|Tumors of Sellar Region|2005|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.6|4.9|4.7|Benign/Borderline|5238|111567226|Female|Tumors of Sellar Region|2006|4.6|4.8|4.7
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.7|4.9|4.8|Benign/Borderline|5355|112783993|Female|Tumors of Sellar Region|2007|4.6|4.9|4.7
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5709|114027722|Female|Tumors of Sellar Region|2008|4.9|5.1|5.0
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.4|5.7|5.5|Benign/Borderline|6311|115293599|Female|Tumors of Sellar Region|2009|5.3|5.6|5.5
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.4|5.5|5.4|Benign/Borderline|31307|584684605|Female|Tumors of Sellar Region|2009-2013|5.3|5.4|5.4
20+|0.0|0.0|0.0|Malignant|72|584684605|Female|Tumors of Sellar Region|2009-2013|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6177|116623212|Female|Tumors of Sellar Region|2010|5.2|5.4|5.3
20+|~|~|~|Malignant|~|116623212|Female|Tumors of Sellar Region|2010|~|~|~
20+|5.3|5.6|5.4|Benign/Borderline|6256|116968930|Female|Tumors of Sellar Region|2011|5.2|5.5|5.3
20+|~|~|~|Malignant|~|116968930|Female|Tumors of Sellar Region|2011|~|~|~
20+|5.4|5.7|5.5|Benign/Borderline|6446|118257088|Female|Tumors of Sellar Region|2012|5.3|5.6|5.5
20+|~|~|~|Malignant|~|118257088|Female|Tumors of Sellar Region|2012|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|6180|119491470|Female|Tumors of Sellar Region|2013|5.0|5.3|5.2
20+|0.0|0.0|0.0|Malignant|17|119491470|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|11.9|12.3|12.1|Benign/Borderline|14084|109112165|Female|Tumors of the Meninges|2004|12.7|13.1|12.9
20+|0.2|0.3|0.3|Malignant|299|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.4|13.8|13.6|Benign/Borderline|16095|110320645|Female|Tumors of the Meninges|2005|14.4|14.8|14.6
20+|0.2|0.3|0.3|Malignant|306|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.0|14.4|14.2|Benign/Borderline|17070|111567226|Female|Tumors of the Meninges|2006|15.1|15.5|15.3
20+|0.2|0.3|0.2|Malignant|287|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.4|14.8|14.6|Benign/Borderline|17815|112783993|Female|Tumors of the Meninges|2007|15.6|16.0|15.8
20+|0.2|0.3|0.2|Malignant|304|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.0|15.5|15.3|Benign/Borderline|18972|114027722|Female|Tumors of the Meninges|2008|16.4|16.9|16.6
20+|0.2|0.2|0.2|Malignant|267|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|15.9|16.4|16.1|Benign/Borderline|20391|115293599|Female|Tumors of the Meninges|2009|17.4|17.9|17.7
20+|0.2|0.2|0.2|Malignant|226|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|15.4|15.6|15.5|Benign/Borderline|99997|584684605|Female|Tumors of the Meninges|2009-2013|17.0|17.2|17.1
20+|0.2|0.2|0.2|Malignant|1157|584684605|Female|Tumors of the Meninges|2009-2013|0.2|0.2|0.2
20+|15.2|15.6|15.4|Benign/Borderline|19790|116623212|Female|Tumors of the Meninges|2010|16.7|17.2|17.0
20+|0.2|0.2|0.2|Malignant|238|116623212|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|15.2|15.6|15.4|Benign/Borderline|19913|116968930|Female|Tumors of the Meninges|2011|16.8|17.3|17.0
20+|0.1|0.2|0.2|Malignant|210|116968930|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|15.2|15.6|15.4|Benign/Borderline|20205|118257088|Female|Tumors of the Meninges|2012|16.9|17.3|17.1
20+|0.2|0.2|0.2|Malignant|232|118257088|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|14.7|15.2|15.0|Benign/Borderline|19938|119491470|Female|Tumors of the Meninges|2013|16.5|16.9|16.7
20+|0.2|0.2|0.2|Malignant|253|119491470|Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|910|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|708|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1135|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|734|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1093|111567226|Female|Unclassified Tumors|2006|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|732|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1182|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.0
20+|0.5|0.5|0.5|Malignant|661|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1267|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|773|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.2|1.1|Benign/Borderline|1391|115293599|Female|Unclassified Tumors|2009|1.1|1.3|1.2
20+|0.5|0.6|0.6|Malignant|793|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.2|1.1|Benign/Borderline|7118|584684605|Female|Unclassified Tumors|2009-2013|1.2|1.2|1.2
20+|0.5|0.5|0.5|Malignant|3340|584684605|Female|Unclassified Tumors|2009-2013|0.6|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|1428|116623212|Female|Unclassified Tumors|2010|1.2|1.3|1.2
20+|0.4|0.5|0.5|Malignant|655|116623212|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.3|1.2|Benign/Borderline|1475|116968930|Female|Unclassified Tumors|2011|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|637|116968930|Female|Unclassified Tumors|2011|0.5|0.6|0.5
20+|1.1|1.2|1.2|Benign/Borderline|1463|118257088|Female|Unclassified Tumors|2012|1.2|1.3|1.2
20+|0.4|0.5|0.5|Malignant|643|118257088|Female|Unclassified Tumors|2012|0.5|0.6|0.5
20+|1.0|1.1|1.1|Benign/Borderline|1375|119491470|Female|Unclassified Tumors|2013|1.1|1.2|1.2
20+|0.4|0.5|0.4|Malignant|625|119491470|Female|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|53|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|47|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|61|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|56|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|71|115293599|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|396|584684605|Female|Unique astrocytoma variants|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|137|584684605|Female|Unique astrocytoma variants|2009-2013|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|68|116623212|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|116623212|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|78|116968930|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|116968930|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|97|118257088|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|118257088|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|119491470|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|119491470|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|104488268|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|63|549649759|Male|All other|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|89|549649759|Male|All other|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109538414|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109538414|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|109918619|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|109918619|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111320238|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|21|111320238|Male|All other|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112643074|Male|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|29|112643074|Male|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|669|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|691|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|696|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|665|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|710|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|706|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|549649759|Male|Anaplastic astrocytoma|2009-2013|~|~|~
20+|0.6|0.7|0.7|Malignant|3597|549649759|Male|Anaplastic astrocytoma|2009-2013|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109538414|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|695|109538414|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|109918619|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|701|109918619|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|111320238|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|739|111320238|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|112643074|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|763|112643074|Male|Anaplastic astrocytoma|2013|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|204|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|204|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|213|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|178|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|189|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|184|108197539|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|549649759|Male|Anaplastic oligodendroglioma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Malignant|935|549649759|Male|Anaplastic oligodendroglioma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109538414|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|187|109538414|Male|Anaplastic oligodendroglioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109918619|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|174|109918619|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111320238|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|181|111320238|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112643074|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|210|112643074|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|636|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|631|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|648|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|623|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|622|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|568|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|549649759|Male|Astrocytoma, NOS|2009-2013|~|~|~
20+|0.5|0.5|0.5|Malignant|2835|549649759|Male|Astrocytoma, NOS|2009-2013|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109538414|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|607|109538414|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|109918619|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|565|109918619|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111320238|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|547|111320238|Male|Astrocytoma, NOS|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112643074|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.5|Malignant|551|112643074|Male|Astrocytoma, NOS|2013|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|23|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|156|549649759|Male|Choroid plexus|2009-2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|549649759|Male|Choroid plexus|2009-2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|109538414|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109538414|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|109918619|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109918619|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|111320238|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111320238|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|112643074|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112643074|Male|Choroid plexus|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|181|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|231|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|188|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|194|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|196|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1000|549649759|Male|Craniopharyngioma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|549649759|Male|Craniopharyngioma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|197|109538414|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109538414|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|187|109918619|Male|Craniopharyngioma|2011|0.1|0.2|0.2
20+|~|~|~|Malignant|~|109918619|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|207|111320238|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111320238|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|212|112643074|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112643074|Male|Craniopharyngioma|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|143|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|207|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|549649759|Male|Diffuse astrocytoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|733|549649759|Male|Diffuse astrocytoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109538414|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|186|109538414|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109918619|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|134|109918619|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111320238|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|112|111320238|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112643074|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|98|112643074|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|96|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|95|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|549649759|Male|Embryonal/primitive/medulloblastoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|559|549649759|Male|Embryonal/primitive/medulloblastoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109538414|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109538414|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109918619|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|109918619|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111320238|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|90|111320238|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112643074|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|95|112643074|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|140|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|158|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|147|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|752|549649759|Male|Ependymoma variants|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|549649759|Male|Ependymoma variants|2009-2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|151|109538414|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109538414|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|109918619|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109918619|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|111320238|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111320238|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|112643074|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112643074|Male|Ependymoma variants|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|297|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|299|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|285|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|284|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|319|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|330|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|34|549649759|Male|Ependymoma/anaplastic ependymoma|2009-2013|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1538|549649759|Male|Ependymoma/anaplastic ependymoma|2009-2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109538414|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|319|109538414|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109918619|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|288|109918619|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111320238|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|316|111320238|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112643074|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|288|112643074|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|52|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|127|549649759|Male|Germ Cell Tumors|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|233|549649759|Male|Germ Cell Tumors|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|109538414|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109538414|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|23|109918619|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|57|109918619|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|27|111320238|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|111320238|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|112643074|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|44|112643074|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5473|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.4|5.7|5.6|Malignant|5521|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5504|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5805|105697783|Male|Glioblastoma|2007|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.6|Malignant|5987|106947980|Male|Glioblastoma|2008|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.5|Malignant|5995|108197539|Male|Glioblastoma|2009|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|549649759|Male|Glioblastoma|2009-2013|~|~|~
20+|5.5|5.6|5.5|Malignant|31111|549649759|Male|Glioblastoma|2009-2013|5.6|5.7|5.7
20+|~|~|~|Benign/Borderline|~|109538414|Male|Glioblastoma|2010|~|~|~
20+|5.3|5.6|5.5|Malignant|6091|109538414|Male|Glioblastoma|2010|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|109918619|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.6|5.5|Malignant|6214|109918619|Male|Glioblastoma|2011|5.5|5.8|5.7
20+|~|~|~|Benign/Borderline|~|111320238|Male|Glioblastoma|2012|~|~|~
20+|5.4|5.7|5.6|Malignant|6439|111320238|Male|Glioblastoma|2012|5.6|5.9|5.8
20+|~|~|~|Benign/Borderline|~|112643074|Male|Glioblastoma|2013|~|~|~
20+|5.3|5.6|5.5|Malignant|6469|112643074|Male|Glioblastoma|2013|5.6|5.9|5.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|424|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|438|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|438|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|455|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|106947980|Male|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|468|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|446|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|66|549649759|Male|Glioma malignant, NOS|2009-2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2209|549649759|Male|Glioma malignant, NOS|2009-2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109538414|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|404|109538414|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109918619|Male|Glioma malignant, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|476|109918619|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|111320238|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|463|111320238|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112643074|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|427|112643074|Male|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.2|0.3|0.2|Benign/Borderline|242|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|283|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|275|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|250|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|289|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|268|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1359|549649759|Male|Hemangioblastoma|2009-2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|549649759|Male|Hemangioblastoma|2009-2013|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|300|109538414|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109538414|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|264|109918619|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|109918619|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|271|111320238|Male|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|111320238|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|262|112643074|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|112643074|Male|Hemangioblastoma|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|134|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|189|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|104488268|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|258|105697783|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|308|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|408|108197539|Male|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2247|549649759|Male|Hemangioma|2009-2013|0.4|0.4|0.4
20+|~|~|~|Malignant|~|549649759|Male|Hemangioma|2009-2013|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|422|109538414|Male|Hemangioma|2010|0.3|0.4|0.4
20+|~|~|~|Malignant|~|109538414|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|473|109918619|Male|Hemangioma|2011|0.4|0.5|0.4
20+|~|~|~|Malignant|~|109918619|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|474|111320238|Male|Hemangioma|2012|0.4|0.5|0.4
20+|~|~|~|Malignant|~|111320238|Male|Hemangioma|2012|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|471|112643074|Male|Hemangioma|2013|0.4|0.5|0.4
20+|~|~|~|Malignant|~|112643074|Male|Hemangioma|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|24|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|34|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|30|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|549649759|Male|Local Extensions from Regional Tumors|2009-2013|~|~|~
20+|0.0|0.0|0.0|Malignant|135|549649759|Male|Local Extensions from Regional Tumors|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109538414|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|29|109538414|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109918619|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|109918619|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111320238|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|111320238|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112643074|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112643074|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|748|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|775|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|759|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|733|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.7|Malignant|770|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|756|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.8|0.7
20+|~|~|~|Benign/Borderline|~|549649759|Male|Lymphomas and Hematopoietic Neoplasms|2009-2013|~|~|~
20+|0.7|0.7|0.7|Malignant|3750|549649759|Male|Lymphomas and Hematopoietic Neoplasms|2009-2013|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109538414|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|752|109538414|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109918619|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|795|109918619|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|111320238|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|747|111320238|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|112643074|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|713|112643074|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|5.0|5.3|5.1|Benign/Borderline|4815|101938779|Male|Meningioma|2004|4.6|4.9|4.7
20+|0.2|0.2|0.2|Malignant|168|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.5|5.8|5.6|Benign/Borderline|5340|103190694|Male|Meningioma|2005|5.0|5.3|5.2
20+|0.1|0.2|0.2|Malignant|157|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.8|6.1|5.9|Benign/Borderline|5759|104488268|Male|Meningioma|2006|5.4|5.7|5.5
20+|0.1|0.2|0.2|Malignant|151|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|5.8|6.2|6.0|Benign/Borderline|5942|105697783|Male|Meningioma|2007|5.5|5.8|5.6
20+|0.2|0.2|0.2|Malignant|178|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.2|6.5|6.4|Benign/Borderline|6477|106947980|Male|Meningioma|2008|5.9|6.2|6.1
20+|0.1|0.2|0.1|Malignant|147|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.6|7.0|6.8|Benign/Borderline|6963|108197539|Male|Meningioma|2009|6.3|6.6|6.4
20+|0.1|0.2|0.1|Malignant|150|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.5|6.7|6.6|Benign/Borderline|35182|549649759|Male|Meningioma|2009-2013|6.3|6.5|6.4
20+|0.1|0.1|0.1|Malignant|699|549649759|Male|Meningioma|2009-2013|0.1|0.1|0.1
20+|6.4|6.8|6.6|Benign/Borderline|6921|109538414|Male|Meningioma|2010|6.2|6.5|6.3
20+|0.1|0.1|0.1|Malignant|119|109538414|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.4|6.7|6.6|Benign/Borderline|7039|109918619|Male|Meningioma|2011|6.3|6.6|6.4
20+|0.1|0.2|0.1|Malignant|139|109918619|Male|Meningioma|2011|0.1|0.1|0.1
20+|6.3|6.6|6.4|Benign/Borderline|7020|111320238|Male|Meningioma|2012|6.2|6.5|6.3
20+|0.1|0.1|0.1|Malignant|141|111320238|Male|Meningioma|2012|0.1|0.1|0.1
20+|6.4|6.7|6.6|Benign/Borderline|7329|112643074|Male|Meningioma|2013|6.4|6.7|6.5
20+|0.1|0.2|0.1|Malignant|150|112643074|Male|Meningioma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|289|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|330|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|362|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|342|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|330|106947980|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|386|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|549649759|Male|Mixed glioma|2009-2013|~|~|~
20+|0.3|0.3|0.3|Malignant|1765|549649759|Male|Mixed glioma|2009-2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109538414|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|340|109538414|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109918619|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|356|109918619|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111320238|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|324|111320238|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112643074|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|364|112643074|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|0.5|0.6|0.5|Benign/Borderline|496|101938779|Male|Neoplasm, unspecified|2004|0.4|0.5|0.5
20+|0.6|0.8|0.7|Malignant|617|101938779|Male|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|623|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|607|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|605|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|576|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|587|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|574|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|593|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|625|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|602|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|645|108197539|Male|Neoplasm, unspecified|2009|0.6|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|3161|549649759|Male|Neoplasm, unspecified|2009-2013|0.6|0.6|0.6
20+|0.6|0.6|0.6|Malignant|3017|549649759|Male|Neoplasm, unspecified|2009-2013|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|639|109538414|Male|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|599|109538414|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|612|109918619|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|604|109918619|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|676|111320238|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|595|111320238|Male|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|637|112643074|Male|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|593|112643074|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2279|101938779|Male|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2622|103190694|Male|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2578|104488268|Male|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2652|105697783|Male|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2616|106947980|Male|Nerve sheath, benign and malignant|2008|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2754|108197539|Male|Nerve sheath, benign and malignant|2009|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|13943|549649759|Male|Nerve sheath, benign and malignant|2009-2013|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|102|549649759|Male|Nerve sheath, benign and malignant|2009-2013|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2719|109538414|Male|Nerve sheath, benign and malignant|2010|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|109538414|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2752|109918619|Male|Nerve sheath, benign and malignant|2011|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|16|109918619|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2923|111320238|Male|Nerve sheath, benign and malignant|2012|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|26|111320238|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2829|112643074|Male|Nerve sheath, benign and malignant|2013|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|112643074|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|23|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|549649759|Male|Neuroepithelial|2009-2013|~|~|~
20+|0.0|0.0|0.0|Malignant|126|549649759|Male|Neuroepithelial|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109538414|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109538414|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109918619|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109918619|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111320238|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|26|111320238|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112643074|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112643074|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|158|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|184|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|193|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|183|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|211|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1006|549649759|Male|Neuronal/glial, neuronal|2009-2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|93|549649759|Male|Neuronal/glial, neuronal|2009-2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|223|109538414|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109538414|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|180|109918619|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|109918619|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|198|111320238|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|111320238|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|196|112643074|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|112643074|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|471|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|436|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|456|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|431|105697783|Male|Oligodendroglioma|2007|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|393|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|459|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|549649759|Male|Oligodendroglioma|2009-2013|~|~|~
20+|0.4|0.4|0.4|Malignant|2056|549649759|Male|Oligodendroglioma|2009-2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109538414|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|457|109538414|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109918619|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|432|109918619|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111320238|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|358|111320238|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112643074|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|356|112643074|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|80|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|70|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|105697783|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|101|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|399|549649759|Male|Other mesenchymal|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|193|549649759|Male|Other mesenchymal|2009-2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|109538414|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|109538414|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|65|109918619|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|41|109918619|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|87|111320238|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|111320238|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|71|112643074|Male|Other mesenchymal|2013|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|112643074|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|150|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|549649759|Male|Pilocytic astrocytoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|741|549649759|Male|Pilocytic astrocytoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109538414|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|109538414|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109918619|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|167|109918619|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111320238|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|141|111320238|Male|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112643074|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|137|112643074|Male|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|77|549649759|Male|Pineal parenchymal|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|108|549649759|Male|Pineal parenchymal|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109538414|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109538414|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|109918619|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|109918619|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|111320238|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|111320238|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112643074|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|35|112643074|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|3299|101938779|Male|Pituitary|2004|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|19|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.5|3.7|3.6|Benign/Borderline|3620|103190694|Male|Pituitary|2005|3.4|3.6|3.5
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.7|3.9|3.8|Benign/Borderline|3899|104488268|Male|Pituitary|2006|3.6|3.9|3.7
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|3.9|4.2|4.1|Benign/Borderline|4252|105697783|Male|Pituitary|2007|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.2|4.5|4.4|Benign/Borderline|4636|106947980|Male|Pituitary|2008|4.2|4.5|4.3
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.4|4.7|4.5|Benign/Borderline|4905|108197539|Male|Pituitary|2009|4.4|4.7|4.5
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.6|4.7|4.6|Benign/Borderline|25573|549649759|Male|Pituitary|2009-2013|4.6|4.7|4.7
20+|0.0|0.0|0.0|Malignant|84|549649759|Male|Pituitary|2009-2013|0.0|0.0|0.0
20+|4.4|4.7|4.5|Benign/Borderline|5005|109538414|Male|Pituitary|2010|4.4|4.7|4.6
20+|~|~|~|Malignant|~|109538414|Male|Pituitary|2010|~|~|~
20+|4.5|4.7|4.6|Benign/Borderline|5079|109918619|Male|Pituitary|2011|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|21|109918619|Male|Pituitary|2011|0.0|0.0|0.0
20+|4.6|4.9|4.8|Benign/Borderline|5371|111320238|Male|Pituitary|2012|4.7|5.0|4.8
20+|0.0|0.0|0.0|Malignant|18|111320238|Male|Pituitary|2012|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|5274|112643074|Male|Pituitary|2013|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|24|112643074|Male|Pituitary|2013|0.0|0.0|0.0
20+|12.1|12.5|12.3|Benign/Borderline|11989|101938779|Male|Total|2004|11.6|12.0|11.8
20+|10.7|11.1|10.9|Malignant|10623|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.4|13.9|13.7|Benign/Borderline|13517|103190694|Male|Total|2005|12.9|13.3|13.1
20+|10.6|11.1|10.9|Malignant|10757|103190694|Male|Total|2005|10.2|10.6|10.4
20+|13.8|14.3|14.1|Benign/Borderline|14173|104488268|Male|Total|2006|13.3|13.8|13.6
20+|10.5|10.9|10.7|Malignant|10795|104488268|Male|Total|2006|10.1|10.5|10.3
20+|14.2|14.6|14.4|Benign/Borderline|14762|105697783|Male|Total|2007|13.7|14.2|14.0
20+|10.4|10.9|10.6|Malignant|11014|105697783|Male|Total|2007|10.2|10.6|10.4
20+|14.9|15.4|15.2|Benign/Borderline|15814|106947980|Male|Total|2008|14.6|15.0|14.8
20+|10.5|11.0|10.7|Malignant|11304|106947980|Male|Total|2008|10.4|10.8|10.6
20+|15.6|16.1|15.9|Benign/Borderline|16816|108197539|Male|Total|2009|15.3|15.8|15.5
20+|10.4|10.8|10.6|Malignant|11352|108197539|Male|Total|2009|10.3|10.7|10.5
20+|15.6|15.8|15.7|Benign/Borderline|85946|549649759|Male|Total|2009-2013|15.5|15.7|15.6
20+|10.2|10.3|10.3|Malignant|56874|549649759|Male|Total|2009-2013|10.3|10.4|10.3
20+|15.4|15.9|15.6|Benign/Borderline|16926|109538414|Male|Total|2010|15.2|15.7|15.5
20+|10.1|10.5|10.3|Malignant|11301|109538414|Male|Total|2010|10.1|10.5|10.3
20+|15.4|15.8|15.6|Benign/Borderline|17073|109918619|Male|Total|2011|15.3|15.8|15.5
20+|10.1|10.5|10.3|Malignant|11440|109918619|Male|Total|2011|10.2|10.6|10.4
20+|15.6|16.1|15.8|Benign/Borderline|17658|111320238|Male|Total|2012|15.6|16.1|15.9
20+|9.9|10.3|10.1|Malignant|11447|111320238|Male|Total|2012|10.1|10.5|10.3
20+|15.3|15.8|15.5|Benign/Borderline|17681|112643074|Male|Total|2013|15.5|15.9|15.7
20+|9.8|10.1|10.0|Malignant|11502|112643074|Male|Total|2013|10.0|10.4|10.2
20+|2.1|2.3|2.2|Benign/Borderline|2279|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2622|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2579|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2653|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2618|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2757|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|13956|549649759|Male|Tumors of Cranial and Spinal Nerves|2009-2013|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|102|549649759|Male|Tumors of Cranial and Spinal Nerves|2009-2013|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2720|109538414|Male|Tumors of Cranial and Spinal Nerves|2010|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|109538414|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2755|109918619|Male|Tumors of Cranial and Spinal Nerves|2011|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|16|109918619|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2925|111320238|Male|Tumors of Cranial and Spinal Nerves|2012|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|26|111320238|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2833|112643074|Male|Tumors of Cranial and Spinal Nerves|2013|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|112643074|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|438|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8942|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|509|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.5|0.5
20+|8.9|9.3|9.1|Malignant|9051|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|542|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9151|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|8.9|8.8
20+|0.4|0.5|0.5|Benign/Borderline|510|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.8|9.1|9.0|Malignant|9338|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|569|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.2|9.0|Malignant|9593|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.8|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|580|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.8|9.1|8.9|Malignant|9650|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|2928|549649759|Male|Tumors of Neuroepthelial Tissue|2009-2013|0.5|0.6|0.5
20+|8.6|8.8|8.7|Malignant|48594|549649759|Male|Tumors of Neuroepthelial Tissue|2009-2013|8.8|8.9|8.8
20+|0.5|0.6|0.6|Benign/Borderline|620|109538414|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.6|8.9|8.8|Malignant|9663|109538414|Male|Tumors of Neuroepthelial Tissue|2010|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|573|109918619|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.5|8.9|8.7|Malignant|9726|109918619|Male|Tumors of Neuroepthelial Tissue|2011|8.7|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|600|111320238|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.5
20+|8.4|8.8|8.6|Malignant|9810|111320238|Male|Tumors of Neuroepthelial Tissue|2012|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|565|112643074|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.5|0.5
20+|8.3|8.7|8.5|Malignant|9879|112643074|Male|Tumors of Neuroepthelial Tissue|2013|8.6|8.9|8.8
20+|3.4|3.6|3.5|Benign/Borderline|3480|101938779|Male|Tumors of Sellar Region|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|19|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|3851|103190694|Male|Tumors of Sellar Region|2005|3.6|3.9|3.7
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.9|4.1|4.0|Benign/Borderline|4087|104488268|Male|Tumors of Sellar Region|2006|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.1|4.4|4.2|Benign/Borderline|4446|105697783|Male|Tumors of Sellar Region|2007|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.4|4.7|4.6|Benign/Borderline|4832|106947980|Male|Tumors of Sellar Region|2008|4.4|4.6|4.5
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|5103|108197539|Male|Tumors of Sellar Region|2009|4.6|4.8|4.7
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.7|4.8|4.8|Benign/Borderline|26573|549649759|Male|Tumors of Sellar Region|2009-2013|4.8|4.9|4.8
20+|0.0|0.0|0.0|Malignant|85|549649759|Male|Tumors of Sellar Region|2009-2013|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|5202|109538414|Male|Tumors of Sellar Region|2010|4.6|4.9|4.7
20+|~|~|~|Malignant|~|109538414|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.6|4.9|4.7|Benign/Borderline|5266|109918619|Male|Tumors of Sellar Region|2011|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|22|109918619|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|4.8|5.1|5.0|Benign/Borderline|5578|111320238|Male|Tumors of Sellar Region|2012|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|18|111320238|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|4.6|4.9|4.8|Benign/Borderline|5486|112643074|Male|Tumors of Sellar Region|2013|4.7|5.0|4.9
20+|0.0|0.0|0.0|Malignant|24|112643074|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.3|5.6|5.4|Benign/Borderline|5137|101938779|Male|Tumors of the Meninges|2004|4.9|5.2|5.0
20+|0.2|0.2|0.2|Malignant|198|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.8|6.1|6.0|Benign/Borderline|5693|103190694|Male|Tumors of the Meninges|2005|5.4|5.7|5.5
20+|0.2|0.2|0.2|Malignant|195|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.1|6.4|6.3|Benign/Borderline|6102|104488268|Male|Tumors of the Meninges|2006|5.7|6.0|5.8
20+|0.2|0.2|0.2|Malignant|183|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.2|6.5|6.3|Benign/Borderline|6274|105697783|Male|Tumors of the Meninges|2007|5.8|6.1|5.9
20+|0.2|0.2|0.2|Malignant|219|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.6|6.9|6.7|Benign/Borderline|6862|106947980|Male|Tumors of the Meninges|2008|6.3|6.6|6.4
20+|0.2|0.2|0.2|Malignant|194|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.0|7.3|7.1|Benign/Borderline|7332|108197539|Male|Tumors of the Meninges|2009|6.6|6.9|6.8
20+|0.2|0.2|0.2|Malignant|198|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|6.8|7.0|6.9|Benign/Borderline|36940|549649759|Male|Tumors of the Meninges|2009-2013|6.7|6.8|6.7
20+|0.2|0.2|0.2|Malignant|895|549649759|Male|Tumors of the Meninges|2009-2013|0.2|0.2|0.2
20+|6.8|7.1|6.9|Benign/Borderline|7296|109538414|Male|Tumors of the Meninges|2010|6.5|6.8|6.7
20+|0.1|0.2|0.1|Malignant|152|109538414|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|6.7|7.0|6.9|Benign/Borderline|7368|109918619|Male|Tumors of the Meninges|2011|6.6|6.9|6.7
20+|0.1|0.2|0.2|Malignant|181|109918619|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|6.6|6.9|6.7|Benign/Borderline|7378|111320238|Male|Tumors of the Meninges|2012|6.5|6.8|6.6
20+|0.1|0.2|0.1|Malignant|171|111320238|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|6.7|7.0|6.8|Benign/Borderline|7662|112643074|Male|Tumors of the Meninges|2013|6.7|7.0|6.8
20+|0.1|0.2|0.2|Malignant|193|112643074|Male|Tumors of the Meninges|2013|0.1|0.2|0.2
20+|0.6|0.7|0.7|Benign/Borderline|632|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|624|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|813|103190694|Male|Unclassified Tumors|2005|0.7|0.8|0.8
20+|0.6|0.7|0.7|Malignant|616|103190694|Male|Unclassified Tumors|2005|0.6|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|833|104488268|Male|Unclassified Tumors|2006|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|587|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|847|105697783|Male|Unclassified Tumors|2007|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|581|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.8|1.0|0.9|Benign/Borderline|904|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.8
20+|0.6|0.7|0.7|Malignant|635|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1012|108197539|Male|Unclassified Tumors|2009|0.9|1.0|0.9
20+|0.6|0.7|0.7|Malignant|655|108197539|Male|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.0|1.0|1.0|Benign/Borderline|5417|549649759|Male|Unclassified Tumors|2009-2013|1.0|1.0|1.0
20+|0.6|0.6|0.6|Malignant|3080|549649759|Male|Unclassified Tumors|2009-2013|0.5|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1063|109538414|Male|Unclassified Tumors|2010|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|613|109538414|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1087|109918619|Male|Unclassified Tumors|2011|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|621|109918619|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1150|111320238|Male|Unclassified Tumors|2012|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|607|111320238|Male|Unclassified Tumors|2012|0.5|0.6|0.5
20+|0.9|1.1|1.0|Benign/Borderline|1111|112643074|Male|Unclassified Tumors|2013|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|603|112643074|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|96|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|110|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|133|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|120|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|144|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|153|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|816|549649759|Male|Unique astrocytoma variants|2009-2013|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|155|549649759|Male|Unique astrocytoma variants|2009-2013|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|176|109538414|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109538414|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|172|109918619|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|109918619|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|165|111320238|Male|Unique astrocytoma variants|2012|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|26|111320238|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|152|112643074|Male|Unique astrocytoma variants|2013|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|112643074|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|142|1134334364|Male and Female|All other|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|162|1134334364|Male and Female|All other|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|226161626|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|226161626|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|226887549|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|226887549|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|229577326|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|229577326|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|28|232134544|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|50|232134544|Male and Female|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1234|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1205|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1204|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1195|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1208|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1206|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Anaplastic astrocytoma|2009-2013|~|~|~
20+|0.5|0.6|0.6|Malignant|6411|1134334364|Male and Female|Anaplastic astrocytoma|2009-2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.5|Malignant|1260|226161626|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1260|226887549|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1315|229577326|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1386|232134544|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|385|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|370|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|351|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|332|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|357|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|326|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Anaplastic oligodendroglioma|2009-2013|~|~|~
20+|0.1|0.2|0.1|Malignant|1655|1134334364|Male and Female|Anaplastic oligodendroglioma|2009-2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|318|226161626|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|321|226887549|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|342|229577326|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|349|232134544|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1207|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1189|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1180|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1155|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1114|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1051|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Astrocytoma, NOS|2009-2013|~|~|~
20+|0.4|0.5|0.4|Malignant|5153|1134334364|Male and Female|Astrocytoma, NOS|2009-2013|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1082|226161626|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|1018|226887549|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|1028|229577326|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.4|0.4|Malignant|982|232134544|Male and Female|Astrocytoma, NOS|2013|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|61|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|67|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|86|218481776|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|380|1134334364|Male and Female|Choroid plexus|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|1134334364|Male and Female|Choroid plexus|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|83|226161626|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226161626|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|82|226887549|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226887549|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|69|229577326|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|229577326|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|232134544|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|232134544|Male and Female|Choroid plexus|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|379|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|414|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|386|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|410|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|416|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|425|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2110|1134334364|Male and Female|Craniopharyngioma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1134334364|Male and Female|Craniopharyngioma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|429|226161626|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226161626|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|400|226887549|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226887549|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|419|229577326|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|229577326|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|441|232134544|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|232134544|Male and Female|Craniopharyngioma|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|256|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|317|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Diffuse astrocytoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|1327|1134334364|Male and Female|Diffuse astrocytoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|348|226161626|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|245|226887549|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|205|229577326|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|166|232134544|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|165|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|188|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|169|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|214|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|211|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|238|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Embryonal/primitive/medulloblastoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|972|1134334364|Male and Female|Embryonal/primitive/medulloblastoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|197|226161626|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|186|226887549|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|171|229577326|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|181|232134544|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|245|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|266|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|305|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|247|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|258|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1340|1134334364|Male and Female|Ependymoma variants|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|1134334364|Male and Female|Ependymoma variants|2009-2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|271|226161626|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226161626|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|263|226887549|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226887549|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|281|229577326|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|229577326|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|269|232134544|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|232134544|Male and Female|Ependymoma variants|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|588|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|599|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|576|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|578|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|630|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|668|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|63|1134334364|Male and Female|Ependymoma/anaplastic ependymoma|2009-2013|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|3016|1134334364|Male and Female|Ependymoma/anaplastic ependymoma|2009-2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|611|226161626|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|226887549|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|584|226887549|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|615|229577326|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|548|232134544|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|63|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|71|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|275|1134334364|Male and Female|Germ Cell Tumors|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|272|1134334364|Male and Female|Germ Cell Tumors|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|53|226161626|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226161626|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|55|226887549|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|226887549|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|53|229577326|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|229577326|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|232134544|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|232134544|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9563|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.4|Malignant|9670|213511339|Male and Female|Glioblastoma|2005|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9784|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10170|218481776|Male and Female|Glioblastoma|2007|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10385|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10455|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Glioblastoma|2009-2013|~|~|~
20+|4.4|4.5|4.4|Malignant|54245|1134334364|Male and Female|Glioblastoma|2009-2013|4.7|4.8|4.8
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.5|4.4|Malignant|10687|226161626|Male and Female|Glioblastoma|2010|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10758|226887549|Male and Female|Glioblastoma|2011|4.7|4.8|4.7
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11230|229577326|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Glioblastoma|2013|~|~|~
20+|4.3|4.5|4.4|Malignant|11262|232134544|Male and Female|Glioblastoma|2013|4.8|4.9|4.9
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|843|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|827|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|831|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|859|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|900|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|955|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|123|1134334364|Male and Female|Glioma malignant, NOS|2009-2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4389|1134334364|Male and Female|Glioma malignant, NOS|2009-2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|226161626|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|808|226161626|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|226887549|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|905|226887549|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|229577326|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|872|229577326|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|232134544|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|862|232134544|Male and Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|445|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|507|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|493|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|463|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|524|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|498|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2514|1134334364|Male and Female|Hemangioblastoma|2009-2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1134334364|Male and Female|Hemangioblastoma|2009-2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|520|226161626|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226161626|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|501|226887549|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226887549|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|516|229577326|Male and Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|229577326|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|486|232134544|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|232134544|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|359|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|458|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|524|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|613|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|750|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|897|223491138|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|5341|1134334364|Male and Female|Hemangioma|2009-2013|0.5|0.5|0.5
20+|0.0|0.0|0.0|Malignant|17|1134334364|Male and Female|Hemangioma|2009-2013|0.0|0.0|0.0
20+|0.4|0.5|0.5|Benign/Borderline|1046|226161626|Male and Female|Hemangioma|2010|0.4|0.5|0.5
20+|~|~|~|Malignant|~|226161626|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1153|226887549|Male and Female|Hemangioma|2011|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226887549|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1137|229577326|Male and Female|Hemangioma|2012|0.5|0.5|0.5
20+|~|~|~|Malignant|~|229577326|Male and Female|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1111|232134544|Male and Female|Hemangioma|2013|0.5|0.5|0.5
20+|~|~|~|Malignant|~|232134544|Male and Female|Hemangioma|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|52|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|54|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Local Extensions from Regional Tumors|2009-2013|~|~|~
20+|0.0|0.0|0.0|Malignant|239|1134334364|Male and Female|Local Extensions from Regional Tumors|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|51|226161626|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|43|226887549|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|47|229577326|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|45|232134544|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1340|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1435|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1430|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1369|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1469|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.6|0.6|Malignant|1418|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|~|~|~
20+|0.6|0.6|0.6|Malignant|7274|1134334364|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009-2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1499|226161626|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1505|226887549|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1438|229577326|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.6|Malignant|1438|232134544|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|8.6|8.9|8.8|Benign/Borderline|18629|211050944|Male and Female|Meningioma|2004|8.7|9.0|8.8
20+|0.2|0.2|0.2|Malignant|441|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.6|9.9|9.8|Benign/Borderline|21130|213511339|Male and Female|Meningioma|2005|9.8|10.0|9.9
20+|0.2|0.2|0.2|Malignant|436|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.1|10.4|10.2|Benign/Borderline|22527|216055494|Male and Female|Meningioma|2006|10.3|10.6|10.4
20+|0.2|0.2|0.2|Malignant|407|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.4|10.6|10.5|Benign/Borderline|23459|218481776|Male and Female|Meningioma|2007|10.6|10.9|10.7
20+|0.2|0.2|0.2|Malignant|445|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|10.9|11.1|11.0|Benign/Borderline|25111|220975702|Male and Female|Meningioma|2008|11.2|11.5|11.4
20+|0.1|0.2|0.2|Malignant|362|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|11.5|11.8|11.6|Benign/Borderline|27032|223491138|Male and Female|Meningioma|2009|12.0|12.2|12.1
20+|0.1|0.2|0.1|Malignant|351|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.1|11.2|11.2|Benign/Borderline|133556|1134334364|Male and Female|Meningioma|2009-2013|11.7|11.8|11.8
20+|0.1|0.1|0.1|Malignant|1689|1134334364|Male and Female|Meningioma|2009-2013|0.1|0.2|0.1
20+|11.0|11.3|11.2|Benign/Borderline|26397|226161626|Male and Female|Meningioma|2010|11.5|11.8|11.7
20+|0.1|0.2|0.1|Malignant|322|226161626|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.0|11.3|11.2|Benign/Borderline|26630|226887549|Male and Female|Meningioma|2011|11.6|11.9|11.7
20+|0.1|0.2|0.1|Malignant|319|226887549|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|10.9|11.2|11.0|Benign/Borderline|26875|229577326|Male and Female|Meningioma|2012|11.6|11.8|11.7
20+|0.1|0.2|0.1|Malignant|337|229577326|Male and Female|Meningioma|2012|0.1|0.2|0.1
20+|10.7|11.0|10.9|Benign/Borderline|26950|232134544|Male and Female|Meningioma|2013|11.5|11.7|11.6
20+|0.1|0.2|0.1|Malignant|362|232134544|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|484|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|569|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|634|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|582|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|592|220975702|Male and Female|Mixed glioma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|666|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Mixed glioma|2009-2013|~|~|~
20+|0.3|0.3|0.3|Malignant|3055|1134334364|Male and Female|Mixed glioma|2009-2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|608|226161626|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|624|226887549|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|557|229577326|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Mixed glioma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|607|232134544|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|0.5|0.6|0.6|Benign/Borderline|1178|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1319|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1486|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1335|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1392|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1303|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1410|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|1232|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1412|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1384|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1503|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1430|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.6|0.6|Benign/Borderline|7173|1134334364|Male and Female|Neoplasm, unspecified|2009-2013|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|6329|1134334364|Male and Female|Neoplasm, unspecified|2009-2013|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1440|226161626|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1247|226161626|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1404|226887549|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1237|226887549|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1475|229577326|Male and Female|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1233|229577326|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|1368|232134544|Male and Female|Neoplasm, unspecified|2013|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1214|232134544|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|2.2|2.3|2.2|Benign/Borderline|4780|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5372|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5456|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5519|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5569|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5854|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|36|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|29261|1134334364|Male and Female|Nerve sheath, benign and malignant|2009-2013|2.6|2.6|2.6
20+|0.0|0.0|0.0|Malignant|208|1134334364|Male and Female|Nerve sheath, benign and malignant|2009-2013|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5586|226161626|Male and Female|Nerve sheath, benign and malignant|2010|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|44|226161626|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5786|226887549|Male and Female|Nerve sheath, benign and malignant|2011|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|36|226887549|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|6088|229577326|Male and Female|Nerve sheath, benign and malignant|2012|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|51|229577326|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|6006|232134544|Male and Female|Nerve sheath, benign and malignant|2013|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|41|232134544|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|1134334364|Male and Female|Neuroepithelial|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|242|1134334364|Male and Female|Neuroepithelial|2009-2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226161626|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|48|226887549|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|53|229577326|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|45|232134544|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|311|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|366|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|377|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|383|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|414|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|434|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2076|1134334364|Male and Female|Neuronal/glial, neuronal|2009-2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|183|1134334364|Male and Female|Neuronal/glial, neuronal|2009-2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|467|226161626|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|35|226161626|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|413|226887549|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|38|226887549|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|402|229577326|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|229577326|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|368|232134544|Male and Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|232134544|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|822|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|787|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|830|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.4|Malignant|797|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|750|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|814|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Oligodendroglioma|2009-2013|~|~|~
20+|0.3|0.3|0.3|Malignant|3653|1134334364|Male and Female|Oligodendroglioma|2009-2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|782|226161626|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|738|226887549|Male and Female|Oligodendroglioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|641|229577326|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|688|232134544|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|147|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|55|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|151|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|152|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|167|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|73|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|199|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|95|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|193|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|70|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|867|1134334364|Male and Female|Other mesenchymal|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|355|1134334364|Male and Female|Other mesenchymal|2009-2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|169|226161626|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|226161626|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|150|226887549|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|226887549|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|192|229577326|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|229577326|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|164|232134544|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|81|232134544|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|274|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|304|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|306|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|301|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|288|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|269|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1134334364|Male and Female|Pilocytic astrocytoma|2009-2013|~|~|~
20+|0.1|0.1|0.1|Malignant|1464|1134334364|Male and Female|Pilocytic astrocytoma|2009-2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226161626|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|328|226161626|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226887549|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|324|226887549|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|229577326|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|259|229577326|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|232134544|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|288|232134544|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|44|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|269|1134334364|Male and Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|235|1134334364|Male and Female|Pineal parenchymal|2009-2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|53|226161626|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226161626|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|226887549|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226887549|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|57|229577326|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|229577326|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|232134544|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|67|232134544|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|3.3|3.5|3.4|Benign/Borderline|7202|211050944|Male and Female|Pituitary|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|8152|213511339|Male and Female|Pituitary|2005|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|8939|216055494|Male and Female|Pituitary|2006|4.1|4.2|4.1
20+|0.0|0.0|0.0|Malignant|30|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9391|218481776|Male and Female|Pituitary|2007|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|10125|220975702|Male and Female|Pituitary|2008|4.5|4.7|4.6
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|4.8|5.0|4.9|Benign/Borderline|10989|223491138|Male and Female|Pituitary|2009|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|22|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|4.8|4.9|4.9|Benign/Borderline|55770|1134334364|Male and Female|Pituitary|2009-2013|4.9|5.0|4.9
20+|0.0|0.0|0.0|Malignant|153|1134334364|Male and Female|Pituitary|2009-2013|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|10950|226161626|Male and Female|Pituitary|2010|4.8|4.9|4.8
20+|0.0|0.0|0.0|Malignant|28|226161626|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|11122|226887549|Male and Female|Pituitary|2011|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|32|226887549|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|11605|229577326|Male and Female|Pituitary|2012|5.0|5.1|5.1
20+|0.0|0.0|0.0|Malignant|31|229577326|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|4.7|4.8|4.8|Benign/Borderline|11225|232134544|Male and Female|Pituitary|2013|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|40|232134544|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|15.8|16.2|16.0|Benign/Borderline|33978|211050944|Male and Female|Total|2004|15.9|16.3|16.1
20+|9.0|9.2|9.1|Malignant|19343|211050944|Male and Female|Total|2004|9.0|9.3|9.2
20+|17.8|18.1|17.9|Benign/Borderline|38688|213511339|Male and Female|Total|2005|17.9|18.3|18.1
20+|9.0|9.2|9.1|Malignant|19650|213511339|Male and Female|Total|2005|9.1|9.3|9.2
20+|18.5|18.9|18.7|Benign/Borderline|40960|216055494|Male and Female|Total|2006|18.8|19.1|19.0
20+|8.9|9.1|9.0|Malignant|19746|216055494|Male and Female|Total|2006|9.0|9.3|9.1
20+|18.9|19.3|19.1|Benign/Borderline|42494|218481776|Male and Female|Total|2007|19.3|19.6|19.4
20+|8.9|9.1|9.0|Malignant|20049|218481776|Male and Female|Total|2007|9.0|9.3|9.2
20+|19.8|20.2|20.0|Benign/Borderline|45231|220975702|Male and Female|Total|2008|20.3|20.7|20.5
20+|8.9|9.1|9.0|Malignant|20493|220975702|Male and Female|Total|2008|9.1|9.4|9.3
20+|20.9|21.3|21.1|Benign/Borderline|48556|223491138|Male and Female|Total|2009|21.5|21.9|21.7
20+|8.8|9.0|8.9|Malignant|20669|223491138|Male and Female|Total|2009|9.1|9.4|9.2
20+|20.5|20.7|20.6|Benign/Borderline|242430|1134334364|Male and Female|Total|2009-2013|21.3|21.5|21.4
20+|8.6|8.7|8.6|Malignant|102975|1134334364|Male and Female|Total|2009-2013|9.0|9.1|9.1
20+|20.2|20.6|20.4|Benign/Borderline|47756|226161626|Male and Female|Total|2010|20.9|21.3|21.1
20+|8.6|8.8|8.7|Malignant|20557|226161626|Male and Female|Total|2010|9.0|9.2|9.1
20+|20.4|20.7|20.6|Benign/Borderline|48329|226887549|Male and Female|Total|2011|21.1|21.5|21.3
20+|8.5|8.7|8.6|Malignant|20491|226887549|Male and Female|Total|2011|8.9|9.2|9.0
20+|20.5|20.9|20.7|Benign/Borderline|49483|229577326|Male and Female|Total|2012|21.4|21.7|21.6
20+|8.4|8.6|8.5|Malignant|20715|229577326|Male and Female|Total|2012|8.9|9.1|9.0
20+|19.9|20.2|20.1|Benign/Borderline|48861|232134544|Male and Female|Total|2013|20.9|21.2|21.0
20+|8.3|8.5|8.4|Malignant|20825|232134544|Male and Female|Total|2013|8.8|9.1|9.0
20+|2.2|2.3|2.2|Benign/Borderline|4780|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5375|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5458|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5521|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5573|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5860|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|36|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|29283|1134334364|Male and Female|Tumors of Cranial and Spinal Nerves|2009-2013|2.6|2.6|2.6
20+|0.0|0.0|0.0|Malignant|208|1134334364|Male and Female|Tumors of Cranial and Spinal Nerves|2009-2013|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5590|226161626|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|44|226161626|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5791|226887549|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|36|226887549|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|6090|229577326|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|51|229577326|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|6011|232134544|Male and Female|Tumors of Cranial and Spinal Nerves|2013|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|41|232134544|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|813|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.6|7.5|Malignant|15981|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|946|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.4
20+|7.4|7.6|7.5|Malignant|16164|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1014|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|7.3|7.6|7.4|Malignant|16343|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.4|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|985|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16694|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.5|7.8|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1050|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16977|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1082|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.3|7.6|7.4|Malignant|17222|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|5508|1134334364|Male and Female|Tumors of Neuroepthelial Tissue|2009-2013|0.5|0.5|0.5
20+|7.2|7.3|7.2|Malignant|86353|1134334364|Male and Female|Tumors of Neuroepthelial Tissue|2009-2013|7.6|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1155|226161626|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17213|226161626|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1116|226887549|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17159|226887549|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1117|229577326|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17444|229577326|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1053|232134544|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.5
20+|7.0|7.2|7.1|Malignant|17537|232134544|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.4|7.7|7.6
20+|3.5|3.7|3.6|Benign/Borderline|7581|211050944|Male and Female|Tumors of Sellar Region|2004|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|8566|213511339|Male and Female|Tumors of Sellar Region|2005|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9325|216055494|Male and Female|Tumors of Sellar Region|2006|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|32|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9801|218481776|Male and Female|Tumors of Sellar Region|2007|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.7|4.8|4.7|Benign/Borderline|10541|220975702|Male and Female|Tumors of Sellar Region|2008|4.7|4.9|4.8
20+|~|~|~|Malignant|~|220975702|Male and Female|Tumors of Sellar Region|2008|~|~|~
20+|5.0|5.2|5.1|Benign/Borderline|11414|223491138|Male and Female|Tumors of Sellar Region|2009|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|23|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.0|5.1|5.1|Benign/Borderline|57880|1134334364|Male and Female|Tumors of Sellar Region|2009-2013|5.1|5.1|5.1
20+|0.0|0.0|0.0|Malignant|157|1134334364|Male and Female|Tumors of Sellar Region|2009-2013|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|11379|226161626|Male and Female|Tumors of Sellar Region|2010|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|28|226161626|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.0|5.1|5.0|Benign/Borderline|11522|226887549|Male and Female|Tumors of Sellar Region|2011|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|34|226887549|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|12024|229577326|Male and Female|Tumors of Sellar Region|2012|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|31|229577326|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|11666|232134544|Male and Female|Tumors of Sellar Region|2013|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|41|232134544|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|8.9|9.2|9.0|Benign/Borderline|19221|211050944|Male and Female|Tumors of the Meninges|2004|9.0|9.2|9.1
20+|0.2|0.3|0.2|Malignant|497|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.0|10.2|10.1|Benign/Borderline|21788|213511339|Male and Female|Tumors of the Meninges|2005|10.1|10.3|10.2
20+|0.2|0.3|0.2|Malignant|501|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.4|10.7|10.5|Benign/Borderline|23172|216055494|Male and Female|Tumors of the Meninges|2006|10.6|10.9|10.7
20+|0.2|0.2|0.2|Malignant|470|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.6|10.9|10.8|Benign/Borderline|24089|218481776|Male and Female|Tumors of the Meninges|2007|10.9|11.2|11.0
20+|0.2|0.3|0.2|Malignant|523|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.2|11.5|11.3|Benign/Borderline|25834|220975702|Male and Female|Tumors of the Meninges|2008|11.5|11.8|11.7
20+|0.2|0.2|0.2|Malignant|461|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|11.8|12.1|12.0|Benign/Borderline|27723|223491138|Male and Female|Tumors of the Meninges|2009|12.3|12.6|12.4
20+|0.2|0.2|0.2|Malignant|424|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|11.4|11.5|11.5|Benign/Borderline|136937|1134334364|Male and Female|Tumors of the Meninges|2009-2013|12.0|12.1|12.1
20+|0.2|0.2|0.2|Malignant|2052|1134334364|Male and Female|Tumors of the Meninges|2009-2013|0.2|0.2|0.2
20+|11.3|11.6|11.5|Benign/Borderline|27086|226161626|Male and Female|Tumors of the Meninges|2010|11.8|12.1|12.0
20+|0.1|0.2|0.2|Malignant|390|226161626|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|11.3|11.6|11.4|Benign/Borderline|27281|226887549|Male and Female|Tumors of the Meninges|2011|11.9|12.2|12.0
20+|0.1|0.2|0.2|Malignant|391|226887549|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|11.2|11.5|11.3|Benign/Borderline|27583|229577326|Male and Female|Tumors of the Meninges|2012|11.9|12.2|12.0
20+|0.1|0.2|0.2|Malignant|403|229577326|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|11.0|11.3|11.2|Benign/Borderline|27600|232134544|Male and Female|Tumors of the Meninges|2013|11.7|12.0|11.9
20+|0.2|0.2|0.2|Malignant|446|232134544|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1542|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1332|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1948|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1350|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1926|216055494|Male and Female|Unclassified Tumors|2006|0.9|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1319|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2029|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1242|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2171|220975702|Male and Female|Unclassified Tumors|2008|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|1408|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2403|223491138|Male and Female|Unclassified Tumors|2009|1.0|1.1|1.1
20+|0.6|0.7|0.6|Malignant|1448|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.1|1.1|Benign/Borderline|12535|1134334364|Male and Female|Unclassified Tumors|2009-2013|1.1|1.1|1.1
20+|0.5|0.5|0.5|Malignant|6420|1134334364|Male and Female|Unclassified Tumors|2009-2013|0.6|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2491|226161626|Male and Female|Unclassified Tumors|2010|1.1|1.1|1.1
20+|0.5|0.6|0.5|Malignant|1268|226161626|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2562|226887549|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.1
20+|0.5|0.6|0.5|Malignant|1258|226887549|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2613|229577326|Male and Female|Unclassified Tumors|2012|1.1|1.2|1.1
20+|0.5|0.5|0.5|Malignant|1250|229577326|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.5
20+|1.0|1.1|1.0|Benign/Borderline|2486|232134544|Male and Female|Unclassified Tumors|2013|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|1228|232134544|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|149|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|153|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|180|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|181|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|224|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1212|1134334364|Male and Female|Unique astrocytoma variants|2009-2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|292|1134334364|Male and Female|Unique astrocytoma variants|2009-2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|244|226161626|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|45|226161626|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|250|226887549|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|226887549|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|262|229577326|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|229577326|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|235|232134544|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|232134544|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
